run_accession	experiment_accession	sample_accession	study_accession	sample	series_id	library_strategy	platform	library_layout	pairedEnd	taxon_id	sample_name	experiment_title	experiment_name	sample_attribute	characteristics_ch1	sa_tissue	ch1_tissue	sa_antibody	ch1_antibody	sa_gene	ch1_gene	sa_treatment	ch1_treatment
SRR002016	SRX000547	SRS000528	SRP000217	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	ES_STAT3	Illumina sequencing of Mouse genomic fragment library	STAT3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SRR002017	SRX000547	SRS000528	SRP000217	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	ES_STAT3	Illumina sequencing of Mouse genomic fragment library	STAT3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SRR002018	SRX000547	SRS000528	SRP000217	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	ES_STAT3	Illumina sequencing of Mouse genomic fragment library	STAT3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SRR002019	SRX000547	SRS000528	SRP000217	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	ES_STAT3	Illumina sequencing of Mouse genomic fragment library	STAT3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SRR271943	SRX020335	SRS072818	SRP002451	GSM540720	GSE21669,GSE21671	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM540720: Stat3fl/fl FoxP3-GFP<STAT3 wild type>, H3K4me3_ChIPSeq	Stat3fl/fl FoxP3-GFP<STAT3 wild type>, H3K4me3_ChIPSeq	NA	source_name: in vitro polarized Th17 T cells || strain: Stat3fl/fl FoxP3-GFP<STAT3 wild type> || cell type: WT-Th17 polazied T cells from naive || passages: mouse primary T cells cultured in vitro for 3 days and restimulated with IL6 || chip antibody: H3K4me3 || antibody manufacturer: AbCam || antibody catalog number: 8580	strain: Stat3fl/fl FoxP3-GFP<STAT3 wild type> || cell type: WT-Th17 polazied T cells from naive || passages: mouse primary T cells cultured in vitro for 3 days and restimulated with IL6 || chip antibody: H3K4me3 || antibody manufacturer: AbCam || antibody catalog number: 8580	Stat3fl/fl FoxP3-GFP<STAT3 wild type> -;- in vitro polarized Th17 T cells -;- WT-Th17 polazied T cells from naive	WT-Th17 polazied T cells from naive	H3K4me3	H3K4me3	NA	NA	NA	NA
SRR271944	SRX020336	SRS072819	SRP002451	GSM540721	GSE21669,GSE21671	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM540721: Stat3fl/fl FoxP3-GFP, CD4-Cre<STAT3 deficient>, H3K4me3_ChIPSeq	Stat3fl/fl FoxP3-GFP, CD4-Cre<STAT3 deficient>, H3K4me3_ChIPSeq	NA	source_name: in vitro polarized Th17 T cells || strain: Stat3fl/fl FoxP3-GFP, CD4-Cre<STAT3 deficient> || cell type: STAT3-deficient-Th17 polarized T cells from naÃƒÂ¯ve || passages: mouse primary T cells cultured in vitro for 3 days and restimulated with IL6 || chip antibody: H3K4me3 || antibody manufacturer: AbCam || antibody catalog number: 8580	strain: Stat3fl/fl FoxP3-GFP, CD4-Cre<STAT3 deficient> || cell type: STAT3-deficient-Th17 polarized T cells from naïve || passages: mouse primary T cells cultured in vitro for 3 days and restimulated with IL6 || chip antibody: H3K4me3 || antibody manufacturer: AbCam || antibody catalog number: 8580	Stat3fl/fl FoxP3-GFP, CD4-Cre<STAT3 deficient> -;- in vitro polarized Th17 T cells -;- STAT3-deficient-Th17 polarized T cells from naÃƒÂ¯ve	STAT3-deficient-Th17 polarized T cells from naïve	H3K4me3	H3K4me3	NA	NA	NA	NA
SRR271642	SRX020337	SRS072820	SRP002451	GSM540722	GSE21669,GSE21671	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM540722: Stat3fl/fl FoxP3-GFP<STAT3 wild type>, STAT3-ChIPSeq	Stat3fl/fl FoxP3-GFP<STAT3 wild type>, STAT3-ChIPSeq	NA	source_name: in vitro polarized Th17 T cells || strain: Stat3fl/fl FoxP3-GFP<STAT3 wild type> || cell type: WT-Th17 polazied T cells from naive || passages: mouse primary T cells cultured in vitro for 3 days and restimulated with IL6 || chip antibody: Phospho-STAT3(Ser727) || antibody manufacturer: Cell Signaling || antibody catalog number: 9134	strain: Stat3fl/fl FoxP3-GFP<STAT3 wild type> || cell type: WT-Th17 polazied T cells from naive || passages: mouse primary T cells cultured in vitro for 3 days and restimulated with IL6 || chip antibody: Phospho-STAT3(Ser727) || antibody manufacturer: Cell Signaling || antibody catalog number: 9134	Stat3fl/fl FoxP3-GFP<STAT3 wild type> -;- in vitro polarized Th17 T cells -;- WT-Th17 polazied T cells from naive	WT-Th17 polazied T cells from naive	Phospho-STAT3(Ser727)	Phospho-STAT3(Ser727)	NA	NA	NA	NA
SRR069061	SRX028629	SRS117324	SRP003810	GSM580756	GSE23681	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM580756: Stat3_ChIPSeq	Stat3_ChIPSeq	GSM580756: Stat3_ChIPSeq	source_name: CD4+ T cells || strain: C57BL/6 || cell type: CD4+ T cells stimulated by IL-6 and IL23 || chip antibody: phospho-Stat3 (14-6727, ebiosciences, CA)	strain: C57BL/6 || cell type: CD4+ T cells stimulated by IL-6 and IL23 || chip antibody: phospho-Stat3 (14-6727, ebiosciences, CA)	C57BL/6 -;- CD4+ T cells -;- CD4+ T cells stimulated by IL-6 and IL23	CD4+ T cells stimulated by IL-6 and IL23	phospho-Stat3 (14-6727, ebiosciences, CA)	phospho-Stat3 (14-6727, ebiosciences, CA)	NA	NA	NA	NA
ERR361904	ERX334673	ERS364413	ERP004237	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	E-MTAB-2042:3iL hESCs	Illumina HiSeq 2000 sequencing; ChIP-Seq of STAT3 in 3iL Human Embryonic Stem Cells	E-MTAB-2042:3iL_hESCs_pSTAT3	organism: Homo sapiens || cell line: H1 || cell type: embryonic stem cell || sex: male	NA	embryonic stem cell -;- H1	NA	NA	NA	NA	NA	NA	NA
SRR099051	SRX041328	SRS172200	SRP005649	GSM671414	GSE27161	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM671414: STAT3_control_ChIPSeq	STAT3_control_ChIPSeq	GSM671414: STAT3_control_ChIPSeq	source_name: Dendritic Cell in Spleen || antibody: Invtrogen, monoclonal antibody ST3-5G7 || cell type: Dendritic Cell || strain: C57BL/6 || treatment: control	antibody: Invtrogen, monoclonal antibody ST3-5G7 || cell type: Dendritic Cell || strain: C57BL/6 || treatment: control	C57BL/6 -;- Dendritic Cell in Spleen	Dendritic Cell	Invtrogen, monoclonal antibody ST3-5G7	Invtrogen, monoclonal antibody ST3-5G7	NA	NA	control	control
SRR099052	SRX041329	SRS172201	SRP005649	GSM671415	GSE27161	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM671415: IL21_STAT3_ChIPSeq	IL21_STAT3_ChIPSeq	GSM671415: IL21_STAT3_ChIPSeq	source_name: Dendritic Cell in Spleen || antibody: Invtrogen, monoclonal antibody ST3-5G7 || cell type: Dendritic Cell || strain: C57BL/6 || treatment: IL21	antibody: Invtrogen, monoclonal antibody ST3-5G7 || cell type: Dendritic Cell || strain: C57BL/6 || treatment: IL21	C57BL/6 -;- Dendritic Cell in Spleen	Dendritic Cell	Invtrogen, monoclonal antibody ST3-5G7	Invtrogen, monoclonal antibody ST3-5G7	NA	NA	IL21	IL21
SRR099053	SRX041330	SRS172202	SRP005649	GSM671416	GSE27161	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM671416: IL21+GMCSF_STAT3_ChIPSeq	IL21+GMCSF_STAT3_ChIPSeq	GSM671416: IL21+GMCSF_STAT3_ChIPSeq	source_name: Dendritic Cell in Spleen || antibody: Invtrogen, monoclonal antibody ST3-5G7 || cell type: Dendritic Cell || strain: C57BL/6 || treatment: IL-21 and GM-CSF	antibody: Invtrogen, monoclonal antibody ST3-5G7 || cell type: Dendritic Cell || strain: C57BL/6 || treatment: IL-21 and GM-CSF	C57BL/6 -;- Dendritic Cell in Spleen	Dendritic Cell	Invtrogen, monoclonal antibody ST3-5G7	Invtrogen, monoclonal antibody ST3-5G7	NA	NA	IL-21 and GM-CSF	IL-21 and GM-CSF
SRR332191	SRX092402	SRS258092	SRP007865	GSM782663	GSE31529,GSE31531	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM782663: PEC_Untreated_STAT3_ChIPseq	PEC_Untreated_STAT3_ChIPseq	GSM782663: PEC_Untreated_STAT3_ChIPseq	source_name: ChIP in untreated macrophages against STAT3 || strain: C57BL/6JJcl || sex: Male || cell type: Adherent peritoneal exudate macrophages || chip antibody: anti-STAT3 (Santa Cruz sc-482)	strain: C57BL/6JJcl || gender: Male || cell type: Adherent peritoneal exudate macrophages || chip antibody: anti-STAT3 (Santa Cruz sc-482)	C57BL/6JJcl -;- ChIP in untreated macrophages against STAT3 -;- Adherent peritoneal exudate macrophages	Adherent peritoneal exudate macrophages	anti-STAT3 (Santa Cruz sc-482)	anti-STAT3 (Santa Cruz sc-482)	NA	NA	NA	NA
SRR332192	SRX092403	SRS258093	SRP007865	GSM782664	GSE31529,GSE31531	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM782664: PEC_IL10-treated_STAT3_ChIPseq	PEC_IL10-treated_STAT3_ChIPseq	GSM782664: PEC_IL10-treated_STAT3_ChIPseq	source_name: ChIP in IL-10 treated (4 hours) macrophages against STAT3 || strain: C57BL/6JJcl || sex: Male || cell type: Adherent peritoneal exudate macrophages || chip antibody: anti-STAT3 (Santa Cruz sc-482)	strain: C57BL/6JJcl || gender: Male || cell type: Adherent peritoneal exudate macrophages || chip antibody: anti-STAT3 (Santa Cruz sc-482)	C57BL/6JJcl -;- ChIP in IL-10 treated (4 hours) macrophages against STAT3 -;- Adherent peritoneal exudate macrophages	Adherent peritoneal exudate macrophages	anti-STAT3 (Santa Cruz sc-482)	anti-STAT3 (Santa Cruz sc-482)	NA	NA	NA	NA
SRR332193	SRX092404	SRS258094	SRP007865	GSM782665	GSE31529,GSE31531	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM782665: PEC_Untreated_Input_ChIPseq	PEC_Untreated_Input_ChIPseq	GSM782665: PEC_Untreated_Input_ChIPseq	source_name: Input chromatin from untreated macrophages || strain: C57BL/6JJcl || sex: Male || cell type: Adherent peritoneal exudate macrophages || chip antibody: None	strain: C57BL/6JJcl || gender: Male || cell type: Adherent peritoneal exudate macrophages || chip antibody: None	C57BL/6JJcl -;- Input chromatin from untreated macrophages -;- Adherent peritoneal exudate macrophages	Adherent peritoneal exudate macrophages	None	None	NA	NA	NA	NA
SRR332194	SRX092405	SRS258095	SRP007865	GSM782666	GSE31529,GSE31531	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM782666: PEC_IL10-treated_Input_ChIPseq	PEC_IL10-treated_Input_ChIPseq	GSM782666: PEC_IL10-treated_Input_ChIPseq	source_name: Input chromatin from IL-10 treated (4 hours) macrophages || strain: C57BL/6JJcl || sex: Male || cell type: Adherent peritoneal exudate macrophages || chip antibody: None	strain: C57BL/6JJcl || gender: Male || cell type: Adherent peritoneal exudate macrophages || chip antibody: None	C57BL/6JJcl -;- Input chromatin from IL-10 treated (4 hours) macrophages -;- Adherent peritoneal exudate macrophages	Adherent peritoneal exudate macrophages	None	None	NA	NA	NA	NA
SRR353505	SRX101308	SRS267160	SRP007993	GSM817342	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM817342: Yale_ChipSeq_HeLa-S3_Input_std	Yale_ChipSeq_HeLa-S3_Input_std	NA	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000612 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000612 || labversion: remapped from hg18 || replicate: 1	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR353506	SRX101309	SRS267161	SRP007993	GSM817343	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM817343: USC_ChipSeq_HepG2_Input_UCDavis	USC_ChipSeq_HepG2_Input_UCDavis	GSM817343: USC_ChipSeq_HepG2_Input_UCDavis	source_name: HepG2 || biomaterial_provider: ATCC || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH000674 || labversion: remapped from hg18 || replicate: 1	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH000674 || labversion: remapped from hg18 || replicate: 1	HepG2 -;- hepatocellular carcinoma -;- endoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR353507	SRX101310	SRS267162	SRP007993	GSM817344	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM817344: USC_ChipSeq_HCT-116_Input_UCDavis	USC_ChipSeq_HCT-116_Input_UCDavis	GSM817344: USC_ChipSeq_HCT-116_Input_UCDavis	source_name: HCT-116 || biomaterial_provider: ATCC || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HCT-116 || cell organism: human || cell description: colorectal carcinoma (PMID: 7214343) || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH000627 || labversion: remapped from hg18 || replicate: 1	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HCT-116 || cell organism: human || cell description: colorectal carcinoma (PMID: 7214343) || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH000627 || labversion: remapped from hg18 || replicate: 1	HCT-116 -;- colorectal carcinoma (PMID: 7214343) -;- endoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR353665	SRX101464	SRS267270	SRP007993	GSM818744	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM818744: USC_ChipSeq_HeLa-S3_Input_UCDavis	USC_ChipSeq_HeLa-S3_Input_UCDavis	GSM818744: USC_ChipSeq_HeLa-S3_Input_UCDavis	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001754	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001754	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR501923	SRX150356	SRS335748	SRP007993	GSM935276	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935276: Stanford_ChipSeq_HeLa-S3_STAT3_IgG-rab	Stanford_ChipSeq_HeLa-S3_STAT3_IgG-rab	GSM935276: Stanford_ChipSeq_HeLa-S3_STAT3_IgG-rab	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000744 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000744 || replicate: 1	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	STAT3	STAT3	NA	NA	None -;- No special treatment or protocol applies	None
SRR501924	SRX150356	SRS335748	SRP007993	GSM935276	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935276: Stanford_ChipSeq_HeLa-S3_STAT3_IgG-rab	Stanford_ChipSeq_HeLa-S3_STAT3_IgG-rab	GSM935276: Stanford_ChipSeq_HeLa-S3_STAT3_IgG-rab	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000744 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000744 || replicate: 1	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	STAT3	STAT3	NA	NA	None -;- No special treatment or protocol applies	None
SRR501944	SRX150364	SRS335756	SRP007993	GSM935284	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935284: Stanford_ChipSeq_GM15510_Input_IgG-mus	Stanford_ChipSeq_GM15510_Input_IgG-mus	GSM935284: Stanford_ChipSeq_GM15510_Input_IgG-mus	source_name: GM15510 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM15510 || cell organism: human || cell description: lymphoblastoid NIGMS Human Genetic Cell Repository, DNA Polymorphism Discovery Resource Collection, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000713 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM15510 || cell organism: human || cell description: lymphoblastoid NIGMS Human Genetic Cell Repository, DNA Polymorphism Discovery Resource Collection, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000713 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM15510 -;- lymphoblastoid NIGMS Human Genetic Cell Repository, DNA Polymorphism Discovery Resource Collection, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR501945	SRX150364	SRS335756	SRP007993	GSM935284	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935284: Stanford_ChipSeq_GM15510_Input_IgG-mus	Stanford_ChipSeq_GM15510_Input_IgG-mus	GSM935284: Stanford_ChipSeq_GM15510_Input_IgG-mus	source_name: GM15510 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM15510 || cell organism: human || cell description: lymphoblastoid NIGMS Human Genetic Cell Repository, DNA Polymorphism Discovery Resource Collection, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000713 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM15510 || cell organism: human || cell description: lymphoblastoid NIGMS Human Genetic Cell Repository, DNA Polymorphism Discovery Resource Collection, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000713 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM15510 -;- lymphoblastoid NIGMS Human Genetic Cell Repository, DNA Polymorphism Discovery Resource Collection, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR501949	SRX150366	SRS335758	SRP007993	GSM935286	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935286: Stanford_ChipSeq_GM12892_Input_IgG-mus	Stanford_ChipSeq_GM12892_Input_IgG-mus	GSM935286: Stanford_ChipSeq_GM12892_Input_IgG-mus	source_name: GM12892 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12892 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000711 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12892 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000711 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM12892 -;- B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR501950	SRX150366	SRS335758	SRP007993	GSM935286	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935286: Stanford_ChipSeq_GM12892_Input_IgG-mus	Stanford_ChipSeq_GM12892_Input_IgG-mus	GSM935286: Stanford_ChipSeq_GM12892_Input_IgG-mus	source_name: GM12892 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12892 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000711 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12892 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000711 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM12892 -;- B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR501957	SRX150368	SRS335760	SRP007993	GSM935288	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935288: USC_ChipSeq_U2OS_Input_UCDavis	USC_ChipSeq_U2OS_Input_UCDavis	GSM935288: USC_ChipSeq_U2OS_Input_UCDavis	source_name: U2OS || biomaterial_provider: ATCC || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: U2OS || cell organism: human || cell description: osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590) || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH000916	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: U2OS || cell organism: human || cell description: osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590) || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH000916	U2OS -;- osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590) -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502008	SRX150393	SRS335785	SRP007993	GSM935313	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935313: Yale_ChipSeq_HepG2_pravastatin_Input_std	Yale_ChipSeq_HepG2_pravastatin_Input_std	GSM935313: Yale_ChipSeq_HepG2_pravastatin_Input_std	source_name: HepG2 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: pravastatin || treatment description: For sterol deprivation, cells were cultured with pravastatin (2 uM, Sigma) in DMEM with 0.5% BSA for 16 h. (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000640 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: pravastatin || treatment description: For sterol deprivation, cells were cultured with pravastatin (2 uM, Sigma) in DMEM with 0.5% BSA for 16 h. (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000640 || labversion: remapped from hg18 || replicate: 1	HepG2 -;- hepatocellular carcinoma -;- endoderm	NA	Input	Input	NA	NA	pravastatin -;- For sterol deprivation, cells were cultured with pravastatin (2 uM, Sigma) in DMEM with 0.5% BSA for 16 h. (Snyder)	pravastatin
SRR502009	SRX150393	SRS335785	SRP007993	GSM935313	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935313: Yale_ChipSeq_HepG2_pravastatin_Input_std	Yale_ChipSeq_HepG2_pravastatin_Input_std	GSM935313: Yale_ChipSeq_HepG2_pravastatin_Input_std	source_name: HepG2 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: pravastatin || treatment description: For sterol deprivation, cells were cultured with pravastatin (2 uM, Sigma) in DMEM with 0.5% BSA for 16 h. (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000640 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: pravastatin || treatment description: For sterol deprivation, cells were cultured with pravastatin (2 uM, Sigma) in DMEM with 0.5% BSA for 16 h. (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000640 || labversion: remapped from hg18 || replicate: 1	HepG2 -;- hepatocellular carcinoma -;- endoderm	NA	Input	Input	NA	NA	pravastatin -;- For sterol deprivation, cells were cultured with pravastatin (2 uM, Sigma) in DMEM with 0.5% BSA for 16 h. (Snyder)	pravastatin
SRR502010	SRX150393	SRS335785	SRP007993	GSM935313	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935313: Yale_ChipSeq_HepG2_pravastatin_Input_std	Yale_ChipSeq_HepG2_pravastatin_Input_std	GSM935313: Yale_ChipSeq_HepG2_pravastatin_Input_std	source_name: HepG2 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: pravastatin || treatment description: For sterol deprivation, cells were cultured with pravastatin (2 uM, Sigma) in DMEM with 0.5% BSA for 16 h. (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000640 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: pravastatin || treatment description: For sterol deprivation, cells were cultured with pravastatin (2 uM, Sigma) in DMEM with 0.5% BSA for 16 h. (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000640 || labversion: remapped from hg18 || replicate: 1	HepG2 -;- hepatocellular carcinoma -;- endoderm	NA	Input	Input	NA	NA	pravastatin -;- For sterol deprivation, cells were cultured with pravastatin (2 uM, Sigma) in DMEM with 0.5% BSA for 16 h. (Snyder)	pravastatin
SRR502027	SRX150401	SRS335793	SRP007993	GSM935321	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935321: USC_ChipSeq_SH-SY5Y_Input_UCDavis	USC_ChipSeq_SH-SY5Y_Input_UCDavis	GSM935321: USC_ChipSeq_SH-SY5Y_Input_UCDavis	source_name: SH-SY5Y || biomaterial_provider: ATCC || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: SH-SY5Y || cell organism: human || cell description: neuroblastoma clonal subline of the neuroepithelioma cell line SK-N-SH from the 1970 bone marrow biopsy of a 4-year-old girl with metastatic neuroblastoma, trisomy of 1q || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001783	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: SH-SY5Y || cell organism: human || cell description: neuroblastoma clonal subline of the neuroepithelioma cell line SK-N-SH from the 1970 bone marrow biopsy of a 4-year-old girl with metastatic neuroblastoma, trisomy of 1q || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001783	SH-SY5Y -;- neuroblastoma clonal subline of the neuroepithelioma cell line SK-N-SH from the 1970 bone marrow biopsy of a 4-year-old girl with metastatic neuroblastoma, trisomy of 1q -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502028	SRX150402	SRS335794	SRP007993	GSM935322	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935322: Stanford_ChipSeq_GM19099_Input_IgG-mus	Stanford_ChipSeq_GM19099_Input_IgG-mus	GSM935322: Stanford_ChipSeq_GM19099_Input_IgG-mus	source_name: GM19099 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19099 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000740 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19099 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000740 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM19099 -;- lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR502029	SRX150402	SRS335794	SRP007993	GSM935322	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935322: Stanford_ChipSeq_GM19099_Input_IgG-mus	Stanford_ChipSeq_GM19099_Input_IgG-mus	GSM935322: Stanford_ChipSeq_GM19099_Input_IgG-mus	source_name: GM19099 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19099 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000740 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19099 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000740 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM19099 -;- lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR502033	SRX150404	SRS335796	SRP007993	GSM935324	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935324: Stanford_ChipSeq_GM19193_Input_IgG-mus	Stanford_ChipSeq_GM19193_Input_IgG-mus	GSM935324: Stanford_ChipSeq_GM19193_Input_IgG-mus	source_name: GM19193 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19193 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000742 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19193 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000742 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM19193 -;- lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR502034	SRX150404	SRS335796	SRP007993	GSM935324	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935324: Stanford_ChipSeq_GM19193_Input_IgG-mus	Stanford_ChipSeq_GM19193_Input_IgG-mus	GSM935324: Stanford_ChipSeq_GM19193_Input_IgG-mus	source_name: GM19193 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19193 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000742 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19193 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000742 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM19193 -;- lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR502041	SRX150407	SRS335799	SRP007993	GSM935327	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935327: USC_ChipSeq_HEK293-T-REx_Input_UCDavis	USC_ChipSeq_HEK293-T-REx_Input_UCDavis	GSM935327: USC_ChipSeq_HEK293-T-REx_Input_UCDavis	source_name: HEK293-T-REx || biomaterial_provider: Invitrogen || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HEK293-T-REx || cell organism: human || cell description: embryonic kidney cells transformed with Adenovirus 5 DNA stably expressing tetracycline repressor, HEK293 (ATCC number CRL-1573) is the parental cell line, hypotriploid, XXX || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001784	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HEK293-T-REx || cell organism: human || cell description: embryonic kidney cells transformed with Adenovirus 5 DNA stably expressing tetracycline repressor, HEK293 (ATCC number CRL-1573) is the parental cell line, hypotriploid, XXX || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001784	HEK293-T-REx -;- embryonic kidney cells transformed with Adenovirus 5 DNA stably expressing tetracycline repressor, HEK293 (ATCC number CRL-1573) is the parental cell line, hypotriploid, XXX -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502054	SRX150414	SRS335807	SRP007993	GSM935334	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935334: USC_ChipSeq_PBDEFetal_Input_UCDavis	USC_ChipSeq_PBDEFetal_Input_UCDavis	GSM935334: USC_ChipSeq_PBDEFetal_Input_UCDavis	source_name: PBDEFetal || biomaterial_provider: Bouhassira Lab || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: PBDEFetal || cell organism: human || cell description: peripheral blood-derived erythroblasts from 16-19 week human fetal liver || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001786	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: PBDEFetal || cell organism: human || cell description: peripheral blood-derived erythroblasts from 16-19 week human fetal liver || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001786	PBDEFetal -;- peripheral blood-derived erythroblasts from 16-19 week human fetal liver -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502063	SRX150419	SRS335812	SRP007993	GSM935339	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935339: Stanford_ChipSeq_HeLa-S3_Input_IgG-rab	Stanford_ChipSeq_HeLa-S3_Input_IgG-rab	GSM935339: Stanford_ChipSeq_HeLa-S3_Input_IgG-rab	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000744 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000744 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502077	SRX150426	SRS335819	SRP007993	GSM935346	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935346: USC_ChipSeq_HUVEC_Input_UCDavis	USC_ChipSeq_HUVEC_Input_UCDavis	GSM935346: USC_ChipSeq_HUVEC_Input_UCDavis	source_name: HUVEC || biomaterial_provider: Lonza || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HUVEC || cell organism: human || cell description: umbilical vein endothelial cells || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001759 || replicate: 1	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HUVEC || cell organism: human || cell description: umbilical vein endothelial cells || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001759 || replicate: 1	HUVEC -;- umbilical vein endothelial cells -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502090	SRX150433	SRS335826	SRP007993	GSM935353	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935353: USC_ChipSeq_H1-hESC_Input_UCDavis	USC_ChipSeq_H1-hESC_Input_UCDavis	GSM935353: USC_ChipSeq_H1-hESC_Input_UCDavis	source_name: H1-hESC || biomaterial_provider: WiCell Research Institute || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: H1-hESC || cell organism: human || cell description: embryonic stem cells || cell karyotype: normal || cell lineage: inner cell mass || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001751	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: H1-hESC || cell organism: human || cell description: embryonic stem cells || cell karyotype: normal || cell lineage: inner cell mass || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001751	H1-hESC -;- embryonic stem cells -;- inner cell mass	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502099	SRX150437	SRS335830	SRP007993	GSM935357	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935357: Yale_ChipSeq_HeLa-S3_IFNg30_Input_std	Yale_ChipSeq_HeLa-S3_IFNg30_Input_std	GSM935357: Yale_ChipSeq_HeLa-S3_IFNg30_Input_std	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: IFNg30 || treatment description: Interferon gamma treatment - 30 minutes (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000611 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: IFNg30 || treatment description: Interferon gamma treatment - 30 minutes (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000611 || labversion: remapped from hg18 || replicate: 1	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	Input	Input	NA	NA	IFNg30 -;- Interferon gamma treatment - 30 minutes (Snyder)	IFNg30
SRR502102	SRX150439	SRS335832	SRP007993	GSM935359	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935359: Yale_ChipSeq_NB4_Input_std	Yale_ChipSeq_NB4_Input_std	GSM935359: Yale_ChipSeq_NB4_Input_std	source_name: NB4 || biomaterial_provider: Refer to protocol documents for differing sources, UW: DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen) ACC-207 http://www.dsmz.de/ or Yale (Stanford): National Cell Culture Center http://www.nccc.com/ || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: NB4 || cell organism: human || cell description: acute promyelocytic leukemia cell line. (PMID: 1995093) || cell karyotype: cancer || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000617	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: NB4 || cell organism: human || cell description: acute promyelocytic leukemia cell line. (PMID: 1995093) || cell karyotype: cancer || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000617	NB4 -;- acute promyelocytic leukemia cell line. (PMID: 1995093) -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502109	SRX150443	SRS335836	SRP007993	GSM935363	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935363: Yale_ChipSeq_K562_Input_std	Yale_ChipSeq_K562_Input_std	GSM935363: Yale_ChipSeq_K562_Input_std	source_name: K562 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000615 || labversion: remapped from hg18, V2 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000615 || labversion: remapped from hg18, V2 || replicate: 1	K562 -;- leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502110	SRX150443	SRS335836	SRP007993	GSM935363	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935363: Yale_ChipSeq_K562_Input_std	Yale_ChipSeq_K562_Input_std	GSM935363: Yale_ChipSeq_K562_Input_std	source_name: K562 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000615 || labversion: remapped from hg18, V2 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000615 || labversion: remapped from hg18, V2 || replicate: 1	K562 -;- leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502145	SRX150461	SRS335853	SRP007993	GSM935381	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935381: Stanford_ChipSeq_H1-hESC_Input_IgG-rab	Stanford_ChipSeq_H1-hESC_Input_IgG-rab	GSM935381: Stanford_ChipSeq_H1-hESC_Input_IgG-rab	source_name: H1-hESC || biomaterial_provider: WiCell Research Institute || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: H1-hESC || cell organism: human || cell description: embryonic stem cells || cell karyotype: normal || cell lineage: inner cell mass || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH001834	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: H1-hESC || cell organism: human || cell description: embryonic stem cells || cell karyotype: normal || cell lineage: inner cell mass || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH001834	H1-hESC -;- embryonic stem cells -;- inner cell mass	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502162	SRX150467	SRS335859	SRP007993	GSM935387	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935387: Stanford_ChipSeq_GM12891_Input_IgG-mus	Stanford_ChipSeq_GM12891_Input_IgG-mus	GSM935387: Stanford_ChipSeq_GM12891_Input_IgG-mus	source_name: GM12891 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12891 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000709 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12891 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000709 || replicate: 1	GM12891 -;- B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR502163	SRX150467	SRS335859	SRP007993	GSM935387	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935387: Stanford_ChipSeq_GM12891_Input_IgG-mus	Stanford_ChipSeq_GM12891_Input_IgG-mus	GSM935387: Stanford_ChipSeq_GM12891_Input_IgG-mus	source_name: GM12891 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12891 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000709 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12891 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000709 || replicate: 1	GM12891 -;- B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR502168	SRX150470	SRS335862	SRP007993	GSM935390	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935390: Stanford_ChipSeq_GM12878_Input_IgG-mus	Stanford_ChipSeq_GM12878_Input_IgG-mus	GSM935390: Stanford_ChipSeq_GM12878_Input_IgG-mus	source_name: GM12878 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000706 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000706 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM12878 -;- B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502169	SRX150470	SRS335862	SRP007993	GSM935390	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935390: Stanford_ChipSeq_GM12878_Input_IgG-mus	Stanford_ChipSeq_GM12878_Input_IgG-mus	GSM935390: Stanford_ChipSeq_GM12878_Input_IgG-mus	source_name: GM12878 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000706 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000706 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM12878 -;- B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502188	SRX150479	SRS335871	SRP007993	GSM935399	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935399: Harvard_ChipSeq_MCF10A-Er-Src_4OHTAM_1uM_12hr_STAT3_Harvard_Control	Harvard_ChipSeq_MCF10A-Er-Src_4OHTAM_1uM_12hr_STAT3_Harvard_Control	GSM935399: Harvard_ChipSeq_MCF10A-Er-Src_4OHTAM_1uM_12hr_STAT3_Harvard_Control	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: 4OHTAM_1uM_12hr || treatment description: 12 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: 4OHTAM_1uM_12hr || treatment description: 12 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	STAT3	STAT3	NA	NA	4OHTAM_1uM_12hr -;- 12 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl)	4OHTAM_1uM_12hr
SRR502189	SRX150479	SRS335871	SRP007993	GSM935399	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935399: Harvard_ChipSeq_MCF10A-Er-Src_4OHTAM_1uM_12hr_STAT3_Harvard_Control	Harvard_ChipSeq_MCF10A-Er-Src_4OHTAM_1uM_12hr_STAT3_Harvard_Control	GSM935399: Harvard_ChipSeq_MCF10A-Er-Src_4OHTAM_1uM_12hr_STAT3_Harvard_Control	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: 4OHTAM_1uM_12hr || treatment description: 12 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: 4OHTAM_1uM_12hr || treatment description: 12 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	STAT3	STAT3	NA	NA	4OHTAM_1uM_12hr -;- 12 hours with 1 uM 4-hydroxytamoxifen dissolved in ethanol (Struhl)	4OHTAM_1uM_12hr
SRR502215	SRX150492	SRS335884	SRP007993	GSM935413	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935413: Yale_ChipSeq_GM12878_Input_std	Yale_ChipSeq_GM12878_Input_std	GSM935413: Yale_ChipSeq_GM12878_Input_std	source_name: GM12878 || biomaterial_provider: Coriell || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000625	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000625	GM12878 -;- B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502224	SRX150497	SRS335889	SRP007993	GSM935418	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935418: Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_4hr_Input_std	Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_4hr_Input_std	GSM935418: Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_4hr_Input_std	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: EtOH_0.01pct_4hr || treatment description: 4 h with 0.01% Ethanol (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001870	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: EtOH_0.01pct_4hr || treatment description: 4 h with 0.01% Ethanol (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001870	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	Input	Input	NA	NA	EtOH_0.01pct_4hr -;- 4 h with 0.01% Ethanol (Snyder)	EtOH_0.01pct_4hr
SRR502225	SRX150498	SRS335890	SRP007993	GSM935419	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935419: Yale_ChipSeq_K562_IFNa6h_Input_std	Yale_ChipSeq_K562_IFNa6h_Input_std	GSM935419: Yale_ChipSeq_K562_IFNa6h_Input_std	source_name: K562 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: IFNa6h || treatment description: Interferon alpha treatment - 6 hours (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000656	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: IFNa6h || treatment description: Interferon alpha treatment - 6 hours (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000656	K562 -;- leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC -;- mesoderm	NA	Input	Input	NA	NA	IFNa6h -;- Interferon alpha treatment - 6 hours (Snyder)	IFNa6h
SRR502226	SRX150499	SRS335891	SRP007993	GSM935420	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935420: Yale_ChipSeq_K562_IFNg30_Input_std	Yale_ChipSeq_K562_IFNg30_Input_std	GSM935420: Yale_ChipSeq_K562_IFNg30_Input_std	source_name: K562 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: IFNg30 || treatment description: Interferon gamma treatment - 30 minutes (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000657	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: IFNg30 || treatment description: Interferon gamma treatment - 30 minutes (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000657	K562 -;- leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC -;- mesoderm	NA	Input	Input	NA	NA	IFNg30 -;- Interferon gamma treatment - 30 minutes (Snyder)	IFNg30
SRR502227	SRX150500	SRS335892	SRP007993	GSM935421	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935421: USC_ChipSeq_NT2-D1_Input_UCDavis	USC_ChipSeq_NT2-D1_Input_UCDavis	GSM935421: USC_ChipSeq_NT2-D1_Input_UCDavis	source_name: NT2-D1 || biomaterial_provider: ATCC || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: NT2-D1 || cell organism: human || cell description: malignant pluripotent embryonal carcinoma (NTera-2), "The NTERA-2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line derived by cloning the NTERA-2 cell line." - ATCC. (PMID: 6694356) || cell karyotype: cancer || cell lineage: inner cell mass || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH000654	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: NT2-D1 || cell organism: human || cell description: malignant pluripotent embryonal carcinoma (NTera-2), "The NTERA-2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line derived by cloning the NTERA-2 cell line." - ATCC. (PMID: 6694356) || cell karyotype: cancer || cell lineage: inner cell mass || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH000654	NT2-D1 -;- malignant pluripotent embryonal carcinoma (NTera-2), "The NTERA-2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line derived by cloning the NTERA-2 cell line." - ATCC. (PMID: 6694356) -;- inner cell mass	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502228	SRX150501	SRS335893	SRP007993	GSM935422	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935422: Yale_ChipSeq_K562_IFNa30_Input_std	Yale_ChipSeq_K562_IFNa30_Input_std	GSM935422: Yale_ChipSeq_K562_IFNa30_Input_std	source_name: K562 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: IFNa30 || treatment description: 30 m of Interferon alpha (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000655	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: IFNa30 || treatment description: 30 m of Interferon alpha (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000655	K562 -;- leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC -;- mesoderm	NA	Input	Input	NA	NA	IFNa30 -;- 30 m of Interferon alpha (Snyder)	IFNa30
SRR502237	SRX150506	SRS335898	SRP007993	GSM935427	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935427: Yale_ChipSeq_K562_IFNg6h_Input_std	Yale_ChipSeq_K562_IFNg6h_Input_std	GSM935427: Yale_ChipSeq_K562_IFNg6h_Input_std	source_name: K562 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: IFNg6h || treatment description: Interferon gamma treatment - 6 hours (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000658	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: IFNg6h || treatment description: Interferon gamma treatment - 6 hours (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000658	K562 -;- leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC -;- mesoderm	NA	Input	Input	NA	NA	IFNg6h -;- Interferon gamma treatment - 6 hours (Snyder)	IFNg6h
SRR502271	SRX150522	SRS335914	SRP007993	GSM935443	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935443: Stanford_ChipSeq_HepG2_insulin_Input_std	Stanford_ChipSeq_HepG2_insulin_Input_std	GSM935443: Stanford_ChipSeq_HepG2_insulin_Input_std	source_name: HepG2 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: insulin || treatment description: DMEM with 0.5% BSA supplemented with 100 nM insulin and 10 uM 22-hydroxycholesterol for 6 h. (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000756 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: insulin || treatment description: DMEM with 0.5% BSA supplemented with 100 nM insulin and 10 uM 22-hydroxycholesterol for 6 h. (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000756 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	HepG2 -;- hepatocellular carcinoma -;- endoderm	NA	Input	Input	NA	NA	insulin -;- DMEM with 0.5% BSA supplemented with 100 nM insulin and 10 uM 22-hydroxycholesterol for 6 h. (Snyder)	insulin
SRR502272	SRX150522	SRS335914	SRP007993	GSM935443	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935443: Stanford_ChipSeq_HepG2_insulin_Input_std	Stanford_ChipSeq_HepG2_insulin_Input_std	GSM935443: Stanford_ChipSeq_HepG2_insulin_Input_std	source_name: HepG2 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: insulin || treatment description: DMEM with 0.5% BSA supplemented with 100 nM insulin and 10 uM 22-hydroxycholesterol for 6 h. (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000756 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: insulin || treatment description: DMEM with 0.5% BSA supplemented with 100 nM insulin and 10 uM 22-hydroxycholesterol for 6 h. (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000756 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	HepG2 -;- hepatocellular carcinoma -;- endoderm	NA	Input	Input	NA	NA	insulin -;- DMEM with 0.5% BSA supplemented with 100 nM insulin and 10 uM 22-hydroxycholesterol for 6 h. (Snyder)	insulin
SRR502273	SRX150523	SRS335915	SRP007993	GSM935444	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935444: Stanford_ChipSeq_HepG2_forskolin_Input_std	Stanford_ChipSeq_HepG2_forskolin_Input_std	GSM935444: Stanford_ChipSeq_HepG2_forskolin_Input_std	source_name: HepG2 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: forskolin || treatment description: low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000755 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: forskolin || treatment description: low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000755 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	HepG2 -;- hepatocellular carcinoma -;- endoderm	NA	Input	Input	NA	NA	forskolin -;- low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	forskolin
SRR502274	SRX150523	SRS335915	SRP007993	GSM935444	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935444: Stanford_ChipSeq_HepG2_forskolin_Input_std	Stanford_ChipSeq_HepG2_forskolin_Input_std	GSM935444: Stanford_ChipSeq_HepG2_forskolin_Input_std	source_name: HepG2 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: forskolin || treatment description: low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000755 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: forskolin || treatment description: low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000755 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	HepG2 -;- hepatocellular carcinoma -;- endoderm	NA	Input	Input	NA	NA	forskolin -;- low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder)	forskolin
SRR502278	SRX150525	SRS335917	SRP007993	GSM935446	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935446: Stanford_ChipSeq_GM18505_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM18505_TNFa_Input_IgG-rab	GSM935446: Stanford_ChipSeq_GM18505_TNFa_Input_IgG-rab	source_name: GM18505 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18505 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000775 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18505 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000775 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM18505 -;- lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502279	SRX150525	SRS335917	SRP007993	GSM935446	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935446: Stanford_ChipSeq_GM18505_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM18505_TNFa_Input_IgG-rab	GSM935446: Stanford_ChipSeq_GM18505_TNFa_Input_IgG-rab	source_name: GM18505 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18505 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000775 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18505 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000775 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM18505 -;- lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502280	SRX150526	SRS335918	SRP007993	GSM935447	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935447: Stanford_ChipSeq_GM15510_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM15510_TNFa_Input_IgG-rab	GSM935447: Stanford_ChipSeq_GM15510_TNFa_Input_IgG-rab	source_name: GM15510 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM15510 || cell organism: human || cell description: lymphoblastoid NIGMS Human Genetic Cell Repository, DNA Polymorphism Discovery Resource Collection, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000774 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM15510 || cell organism: human || cell description: lymphoblastoid NIGMS Human Genetic Cell Repository, DNA Polymorphism Discovery Resource Collection, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000774 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM15510 -;- lymphoblastoid NIGMS Human Genetic Cell Repository, DNA Polymorphism Discovery Resource Collection, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502281	SRX150526	SRS335918	SRP007993	GSM935447	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935447: Stanford_ChipSeq_GM15510_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM15510_TNFa_Input_IgG-rab	GSM935447: Stanford_ChipSeq_GM15510_TNFa_Input_IgG-rab	source_name: GM15510 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM15510 || cell organism: human || cell description: lymphoblastoid NIGMS Human Genetic Cell Repository, DNA Polymorphism Discovery Resource Collection, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000774 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM15510 || cell organism: human || cell description: lymphoblastoid NIGMS Human Genetic Cell Repository, DNA Polymorphism Discovery Resource Collection, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000774 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM15510 -;- lymphoblastoid NIGMS Human Genetic Cell Repository, DNA Polymorphism Discovery Resource Collection, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502282	SRX150527	SRS335919	SRP007993	GSM935448	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935448: Stanford_ChipSeq_GM18951_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM18951_TNFa_Input_IgG-rab	GSM935448: Stanford_ChipSeq_GM18951_TNFa_Input_IgG-rab	source_name: GM18951 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18951 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Japanese in Tokyo, Japan, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000777 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18951 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Japanese in Tokyo, Japan, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000777 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM18951 -;- lymphoblastoid, International HapMap Project, Japanese in Tokyo, Japan, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502283	SRX150527	SRS335919	SRP007993	GSM935448	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935448: Stanford_ChipSeq_GM18951_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM18951_TNFa_Input_IgG-rab	GSM935448: Stanford_ChipSeq_GM18951_TNFa_Input_IgG-rab	source_name: GM18951 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18951 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Japanese in Tokyo, Japan, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000777 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18951 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Japanese in Tokyo, Japan, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000777 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM18951 -;- lymphoblastoid, International HapMap Project, Japanese in Tokyo, Japan, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502284	SRX150528	SRS335920	SRP007993	GSM935449	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935449: Stanford_ChipSeq_GM18526_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM18526_TNFa_Input_IgG-rab	GSM935449: Stanford_ChipSeq_GM18526_TNFa_Input_IgG-rab	source_name: GM18526 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18526 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000776 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18526 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000776 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM18526 -;- lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502285	SRX150528	SRS335920	SRP007993	GSM935449	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935449: Stanford_ChipSeq_GM18526_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM18526_TNFa_Input_IgG-rab	GSM935449: Stanford_ChipSeq_GM18526_TNFa_Input_IgG-rab	source_name: GM18526 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18526 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000776 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18526 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000776 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM18526 -;- lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502286	SRX150529	SRS335921	SRP007993	GSM935450	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935450: Stanford_ChipSeq_GM12878_Input_IgG-rab	Stanford_ChipSeq_GM12878_Input_IgG-rab	GSM935450: Stanford_ChipSeq_GM12878_Input_IgG-rab	source_name: GM12878 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000771 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000771 || replicate: 1	GM12878 -;- B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502287	SRX150529	SRS335921	SRP007993	GSM935450	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935450: Stanford_ChipSeq_GM12878_Input_IgG-rab	Stanford_ChipSeq_GM12878_Input_IgG-rab	GSM935450: Stanford_ChipSeq_GM12878_Input_IgG-rab	source_name: GM12878 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000771 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000771 || replicate: 1	GM12878 -;- B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502288	SRX150530	SRS335922	SRP007993	GSM935451	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935451: Stanford_ChipSeq_GM10847_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM10847_TNFa_Input_IgG-rab	GSM935451: Stanford_ChipSeq_GM10847_TNFa_Input_IgG-rab	source_name: GM10847 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM10847 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000770 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM10847 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000770 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM10847 -;- lymphoblastoid, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502289	SRX150530	SRS335922	SRP007993	GSM935451	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935451: Stanford_ChipSeq_GM10847_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM10847_TNFa_Input_IgG-rab	GSM935451: Stanford_ChipSeq_GM10847_TNFa_Input_IgG-rab	source_name: GM10847 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM10847 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000770 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM10847 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000770 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM10847 -;- lymphoblastoid, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502290	SRX150531	SRS335923	SRP007993	GSM935452	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935452: Stanford_ChipSeq_GM12892_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM12892_TNFa_Input_IgG-rab	GSM935452: Stanford_ChipSeq_GM12892_TNFa_Input_IgG-rab	source_name: GM12892 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12892 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000773 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12892 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000773 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM12892 -;- B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502291	SRX150531	SRS335923	SRP007993	GSM935452	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935452: Stanford_ChipSeq_GM12892_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM12892_TNFa_Input_IgG-rab	GSM935452: Stanford_ChipSeq_GM12892_TNFa_Input_IgG-rab	source_name: GM12892 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12892 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000773 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12892 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000773 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM12892 -;- B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502292	SRX150532	SRS335924	SRP007993	GSM935453	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935453: Stanford_ChipSeq_GM12891_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM12891_TNFa_Input_IgG-rab	GSM935453: Stanford_ChipSeq_GM12891_TNFa_Input_IgG-rab	source_name: GM12891 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12891 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: M || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000772 || labversion: remapped from hg18 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12891 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: M || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000772 || labversion: remapped from hg18 || replicate: 1	GM12891 -;- B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502293	SRX150532	SRS335924	SRP007993	GSM935453	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935453: Stanford_ChipSeq_GM12891_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM12891_TNFa_Input_IgG-rab	GSM935453: Stanford_ChipSeq_GM12891_TNFa_Input_IgG-rab	source_name: GM12891 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12891 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: M || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000772 || labversion: remapped from hg18 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12891 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: M || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000772 || labversion: remapped from hg18 || replicate: 1	GM12891 -;- B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502294	SRX150533	SRS335925	SRP007993	GSM935454	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935454: Stanford_ChipSeq_GM19193_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM19193_TNFa_Input_IgG-rab	GSM935454: Stanford_ChipSeq_GM19193_TNFa_Input_IgG-rab	source_name: GM19193 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19193 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000779 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19193 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000779 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM19193 -;- lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502295	SRX150533	SRS335925	SRP007993	GSM935454	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935454: Stanford_ChipSeq_GM19193_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM19193_TNFa_Input_IgG-rab	GSM935454: Stanford_ChipSeq_GM19193_TNFa_Input_IgG-rab	source_name: GM19193 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19193 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000779 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19193 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000779 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM19193 -;- lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502296	SRX150534	SRS335926	SRP007993	GSM935455	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935455: Stanford_ChipSeq_GM19099_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM19099_TNFa_Input_IgG-rab	GSM935455: Stanford_ChipSeq_GM19099_TNFa_Input_IgG-rab	source_name: GM19099 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19099 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000778 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19099 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000778 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM19099 -;- lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502297	SRX150534	SRS335926	SRP007993	GSM935455	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935455: Stanford_ChipSeq_GM19099_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM19099_TNFa_Input_IgG-rab	GSM935455: Stanford_ChipSeq_GM19099_TNFa_Input_IgG-rab	source_name: GM19099 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19099 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000778 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM19099 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH000778 || labversion: remapped from hg18, Illumina 2.0, low confidence sequences excluded || replicate: 1	GM19099 -;- lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	Epstein-Barr Virus transformed -;- TNFa
SRR502300	SRX150536	SRS335928	SRP007993	GSM935457	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935457: Harvard_ChipSeq_MCF10A-Er-Src_4OHTAM_1uM_36hr_STAT3_std	Harvard_ChipSeq_MCF10A-Er-Src_4OHTAM_1uM_36hr_STAT3_std	GSM935457: Harvard_ChipSeq_MCF10A-Er-Src_4OHTAM_1uM_36hr_STAT3_std	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: 4OHTAM_1uM_36hr || treatment description: (To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001782 || replicate: 1	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: 4OHTAM_1uM_36hr || treatment description: (To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001782 || replicate: 1	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	STAT3	STAT3	NA	NA	4OHTAM_1uM_36hr -;- (To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers)	4OHTAM_1uM_36hr
SRR502301	SRX150536	SRS335928	SRP007993	GSM935457	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935457: Harvard_ChipSeq_MCF10A-Er-Src_4OHTAM_1uM_36hr_STAT3_std	Harvard_ChipSeq_MCF10A-Er-Src_4OHTAM_1uM_36hr_STAT3_std	GSM935457: Harvard_ChipSeq_MCF10A-Er-Src_4OHTAM_1uM_36hr_STAT3_std	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: 4OHTAM_1uM_36hr || treatment description: (To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001782 || replicate: 1	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: 4OHTAM_1uM_36hr || treatment description: (To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001782 || replicate: 1	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	STAT3	STAT3	NA	NA	4OHTAM_1uM_36hr -;- (To replace TAM_1uM_36hr) 36 h with 1 uM 4-hydroxytamoxifen (Myers)	4OHTAM_1uM_36hr
SRR502306	SRX150539	SRS335931	SRP007993	GSM935460	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935460: USC_ChipSeq_Raji_Input_UCDavis	USC_ChipSeq_Raji_Input_UCDavis	GSM935460: USC_ChipSeq_Raji_Input_UCDavis	source_name: Raji || biomaterial_provider: ATCC || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: Raji || cell organism: human || cell description: B lymphocyte, "The Raji line of lymphoblast-like cells was established by R.J.V. Pulvertaft in 1963 from a Burkitt's lymphoma of the left maxilla of an 11-year-old Black male." - ATCC. (PMID: 14086209) || cell karyotype: cancer || cell lineage: mesoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001760	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: Raji || cell organism: human || cell description: B lymphocyte, "The Raji line of lymphoblast-like cells was established by R.J.V. Pulvertaft in 1963 from a Burkitt's lymphoma of the left maxilla of an 11-year-old Black male." - ATCC. (PMID: 14086209) || cell karyotype: cancer || cell lineage: mesoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001760	Raji -;- B lymphocyte, "The Raji line of lymphoblast-like cells was established by R.J.V. Pulvertaft in 1963 from a Burkitt's lymphoma of the left maxilla of an 11-year-old Black male." - ATCC. (PMID: 14086209) -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502357	SRX150564	SRS335956	SRP007993	GSM935485	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935485: USC_ChipSeq_MCF-7_Input_UCDavis	USC_ChipSeq_MCF-7_Input_UCDavis	GSM935485: USC_ChipSeq_MCF-7_Input_UCDavis	source_name: MCF-7 || biomaterial_provider: ATCC || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF-7 || cell organism: human || cell description: mammary gland, adenocarcinoma. (PMID: 4357757), newly promoted to tier 2: not in 2011 analysis || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH000762 || labversion: MCF7 cells stably expressed a tagged HA-E2F1 were fragmented using Bioruptor, crosslinks were reversed at 67*C overnight and Input was Qiagen purified, || replicate: 1 || softwareversion: PeakSeq1.0 (fdr 0.001)	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF-7 || cell organism: human || cell description: mammary gland, adenocarcinoma. (PMID: 4357757), newly promoted to tier 2: not in 2011 analysis || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH000762 || labversion: MCF7 cells stably expressed a tagged HA-E2F1 were fragmented using Bioruptor, crosslinks were reversed at 67*C overnight and Input was Qiagen purified, || replicate: 1 || softwareversion: PeakSeq1.0 (fdr 0.001)	MCF-7 -;- mammary gland, adenocarcinoma. (PMID: 4357757), newly promoted to tier 2: not in 2011 analysis -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502358	SRX150564	SRS335956	SRP007993	GSM935485	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935485: USC_ChipSeq_MCF-7_Input_UCDavis	USC_ChipSeq_MCF-7_Input_UCDavis	GSM935485: USC_ChipSeq_MCF-7_Input_UCDavis	source_name: MCF-7 || biomaterial_provider: ATCC || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF-7 || cell organism: human || cell description: mammary gland, adenocarcinoma. (PMID: 4357757), newly promoted to tier 2: not in 2011 analysis || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH000762 || labversion: MCF7 cells stably expressed a tagged HA-E2F1 were fragmented using Bioruptor, crosslinks were reversed at 67*C overnight and Input was Qiagen purified, || replicate: 1 || softwareversion: PeakSeq1.0 (fdr 0.001)	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF-7 || cell organism: human || cell description: mammary gland, adenocarcinoma. (PMID: 4357757), newly promoted to tier 2: not in 2011 analysis || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH000762 || labversion: MCF7 cells stably expressed a tagged HA-E2F1 were fragmented using Bioruptor, crosslinks were reversed at 67*C overnight and Input was Qiagen purified, || replicate: 1 || softwareversion: PeakSeq1.0 (fdr 0.001)	MCF-7 -;- mammary gland, adenocarcinoma. (PMID: 4357757), newly promoted to tier 2: not in 2011 analysis -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502408	SRX150589	SRS335981	SRP007993	GSM935510	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935510: Yale_ChipSeq_HUVEC_Input_std	Yale_ChipSeq_HUVEC_Input_std	GSM935510: Yale_ChipSeq_HUVEC_Input_std	source_name: HUVEC || biomaterial_provider: Lonza || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HUVEC || cell organism: human || cell description: umbilical vein endothelial cells || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000780 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HUVEC || cell organism: human || cell description: umbilical vein endothelial cells || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000780 || labversion: remapped from hg18 || replicate: 1	HUVEC -;- umbilical vein endothelial cells -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502409	SRX150589	SRS335981	SRP007993	GSM935510	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935510: Yale_ChipSeq_HUVEC_Input_std	Yale_ChipSeq_HUVEC_Input_std	GSM935510: Yale_ChipSeq_HUVEC_Input_std	source_name: HUVEC || biomaterial_provider: Lonza || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HUVEC || cell organism: human || cell description: umbilical vein endothelial cells || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000780 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HUVEC || cell organism: human || cell description: umbilical vein endothelial cells || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000780 || labversion: remapped from hg18 || replicate: 1	HUVEC -;- umbilical vein endothelial cells -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502413	SRX150591	SRS335983	SRP007993	GSM935512	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935512: Stanford_ChipSeq_IMR90_Input_IgG-rab	Stanford_ChipSeq_IMR90_Input_IgG-rab	GSM935512: Stanford_ChipSeq_IMR90_Input_IgG-rab	source_name: IMR90 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: IMR90 || cell organism: human || cell description: fetal lung fibroblasts, newly promoted to tier 2: not in 2011 analysis || cell karyotype: normal || cell lineage: endoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH002808 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: IMR90 || cell organism: human || cell description: fetal lung fibroblasts, newly promoted to tier 2: not in 2011 analysis || cell karyotype: normal || cell lineage: endoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH002808 || replicate: 1	IMR90 -;- fetal lung fibroblasts, newly promoted to tier 2: not in 2011 analysis -;- endoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502414	SRX150591	SRS335983	SRP007993	GSM935512	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935512: Stanford_ChipSeq_IMR90_Input_IgG-rab	Stanford_ChipSeq_IMR90_Input_IgG-rab	GSM935512: Stanford_ChipSeq_IMR90_Input_IgG-rab	source_name: IMR90 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: IMR90 || cell organism: human || cell description: fetal lung fibroblasts, newly promoted to tier 2: not in 2011 analysis || cell karyotype: normal || cell lineage: endoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH002808 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: IMR90 || cell organism: human || cell description: fetal lung fibroblasts, newly promoted to tier 2: not in 2011 analysis || cell karyotype: normal || cell lineage: endoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH002808 || replicate: 1	IMR90 -;- fetal lung fibroblasts, newly promoted to tier 2: not in 2011 analysis -;- endoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502419	SRX150594	SRS335986	SRP007993	GSM935515	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935515: Stanford_ChipSeq_HepG2_Input_IgG-goat	Stanford_ChipSeq_HepG2_Input_IgG-goat	GSM935515: Stanford_ChipSeq_HepG2_Input_IgG-goat	source_name: HepG2 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-goat || control description: Input signal from Normal Goat IgG ChIP-seq. || control: IgG-goat || control description: Input signal from Normal Goat IgG ChIP-seq. || controlid: wgEncodeEH002803 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-goat || control description: Input signal from Normal Goat IgG ChIP-seq. || control: IgG-goat || control description: Input signal from Normal Goat IgG ChIP-seq. || controlid: wgEncodeEH002803 || replicate: 1	HepG2 -;- hepatocellular carcinoma -;- endoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502420	SRX150594	SRS335986	SRP007993	GSM935515	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935515: Stanford_ChipSeq_HepG2_Input_IgG-goat	Stanford_ChipSeq_HepG2_Input_IgG-goat	GSM935515: Stanford_ChipSeq_HepG2_Input_IgG-goat	source_name: HepG2 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-goat || control description: Input signal from Normal Goat IgG ChIP-seq. || control: IgG-goat || control description: Input signal from Normal Goat IgG ChIP-seq. || controlid: wgEncodeEH002803 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-goat || control description: Input signal from Normal Goat IgG ChIP-seq. || control: IgG-goat || control description: Input signal from Normal Goat IgG ChIP-seq. || controlid: wgEncodeEH002803 || replicate: 1	HepG2 -;- hepatocellular carcinoma -;- endoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502437	SRX150602	SRS335994	SRP007993	GSM935523	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935523: Stanford_ChipSeq_GM18505_Input_IgG-mus	Stanford_ChipSeq_GM18505_Input_IgG-mus	GSM935523: Stanford_ChipSeq_GM18505_Input_IgG-mus	source_name: GM18505 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18505 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000730 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18505 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000730 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM18505 -;- lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR502438	SRX150602	SRS335994	SRP007993	GSM935523	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935523: Stanford_ChipSeq_GM18505_Input_IgG-mus	Stanford_ChipSeq_GM18505_Input_IgG-mus	GSM935523: Stanford_ChipSeq_GM18505_Input_IgG-mus	source_name: GM18505 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18505 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000730 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18505 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000730 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM18505 -;- lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR502442	SRX150604	SRS335996	SRP007993	GSM935525	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935525: Stanford_ChipSeq_GM18526_Input_IgG-mus	Stanford_ChipSeq_GM18526_Input_IgG-mus	GSM935525: Stanford_ChipSeq_GM18526_Input_IgG-mus	source_name: GM18526 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18526 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000732 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18526 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000732 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM18526 -;- lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR502443	SRX150604	SRS335996	SRP007993	GSM935525	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935525: Stanford_ChipSeq_GM18526_Input_IgG-mus	Stanford_ChipSeq_GM18526_Input_IgG-mus	GSM935525: Stanford_ChipSeq_GM18526_Input_IgG-mus	source_name: GM18526 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18526 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000732 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18526 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000732 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM18526 -;- lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR502444	SRX150604	SRS335996	SRP007993	GSM935525	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935525: Stanford_ChipSeq_GM18526_Input_IgG-mus	Stanford_ChipSeq_GM18526_Input_IgG-mus	GSM935525: Stanford_ChipSeq_GM18526_Input_IgG-mus	source_name: GM18526 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18526 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000732 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18526 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000732 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM18526 -;- lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR502453	SRX150607	SRS335999	SRP007993	GSM935528	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935528: Stanford_ChipSeq_GM18951_Input_IgG-mus	Stanford_ChipSeq_GM18951_Input_IgG-mus	GSM935528: Stanford_ChipSeq_GM18951_Input_IgG-mus	source_name: GM18951 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18951 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Japanese in Tokyo, Japan, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000737 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM18951 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, Japanese in Tokyo, Japan, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000737 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM18951 -;- lymphoblastoid, International HapMap Project, Japanese in Tokyo, Japan, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR502469	SRX150612	SRS336004	SRP007993	GSM935533	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935533: Yale_ChipSeq_HEK293_Input_std	Yale_ChipSeq_HEK293_Input_std	GSM935533: Yale_ChipSeq_HEK293_Input_std	source_name: HEK293 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HEK293 || cell organism: human || cell description: embryonic kidney, cells contain Adenovirus 5 DNA (PMID: 11967234) || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000631	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HEK293 || cell organism: human || cell description: embryonic kidney, cells contain Adenovirus 5 DNA (PMID: 11967234) || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH000631	HEK293 -;- embryonic kidney, cells contain Adenovirus 5 DNA (PMID: 11967234) -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502473	SRX150614	SRS336006	SRP007993	GSM935535	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935535: Yale_ChipSeq_HeLa-S3_Input_IgG-mus	Yale_ChipSeq_HeLa-S3_Input_IgG-mus	GSM935535: Yale_ChipSeq_HeLa-S3_Input_IgG-mus	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000633 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000633 || labversion: remapped from hg18 || replicate: 1	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502474	SRX150614	SRS336006	SRP007993	GSM935535	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935535: Yale_ChipSeq_HeLa-S3_Input_IgG-mus	Yale_ChipSeq_HeLa-S3_Input_IgG-mus	GSM935535: Yale_ChipSeq_HeLa-S3_Input_IgG-mus	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000633 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000633 || labversion: remapped from hg18 || replicate: 1	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502475	SRX150615	SRS336007	SRP007993	GSM935536	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935536: Yale_ChipSeq_HeLa-S3_Input_Large_Fragment	Yale_ChipSeq_HeLa-S3_Input_Large_Fragment	GSM935536: Yale_ChipSeq_HeLa-S3_Input_Large_Fragment	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Large_Fragment || control description: Control signal from sonication into large fragments of DNA (350-800 bp). || control: Large_Fragment || control description: Control signal from sonication into large fragments of DNA (350-800 bp). || controlid: wgEncodeEH000634 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Large_Fragment || control description: Control signal from sonication into large fragments of DNA (350-800 bp). || control: Large_Fragment || control description: Control signal from sonication into large fragments of DNA (350-800 bp). || controlid: wgEncodeEH000634 || labversion: remapped from hg18 || replicate: 1	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502476	SRX150615	SRS336007	SRP007993	GSM935536	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935536: Yale_ChipSeq_HeLa-S3_Input_Large_Fragment	Yale_ChipSeq_HeLa-S3_Input_Large_Fragment	GSM935536: Yale_ChipSeq_HeLa-S3_Input_Large_Fragment	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Large_Fragment || control description: Control signal from sonication into large fragments of DNA (350-800 bp). || control: Large_Fragment || control description: Control signal from sonication into large fragments of DNA (350-800 bp). || controlid: wgEncodeEH000634 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Large_Fragment || control description: Control signal from sonication into large fragments of DNA (350-800 bp). || control: Large_Fragment || control description: Control signal from sonication into large fragments of DNA (350-800 bp). || controlid: wgEncodeEH000634 || labversion: remapped from hg18 || replicate: 1	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502477	SRX150616	SRS336008	SRP007993	GSM935537	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935537: Yale_ChipSeq_HeLa-S3_Input_MNase	Yale_ChipSeq_HeLa-S3_Input_MNase	GSM935537: Yale_ChipSeq_HeLa-S3_Input_MNase	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: MNase || control description: Input signal from MNase digested DNA. || control: MNase || control description: Input signal from MNase digested DNA. || controlid: wgEncodeEH000635 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: MNase || control description: Input signal from MNase digested DNA. || control: MNase || control description: Input signal from MNase digested DNA. || controlid: wgEncodeEH000635 || labversion: remapped from hg18 || replicate: 1	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502478	SRX150616	SRS336008	SRP007993	GSM935537	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935537: Yale_ChipSeq_HeLa-S3_Input_MNase	Yale_ChipSeq_HeLa-S3_Input_MNase	GSM935537: Yale_ChipSeq_HeLa-S3_Input_MNase	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: MNase || control description: Input signal from MNase digested DNA. || control: MNase || control description: Input signal from MNase digested DNA. || controlid: wgEncodeEH000635 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: MNase || control description: Input signal from MNase digested DNA. || control: MNase || control description: Input signal from MNase digested DNA. || controlid: wgEncodeEH000635 || labversion: remapped from hg18 || replicate: 1	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502479	SRX150617	SRS336009	SRP007993	GSM935538	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935538: Yale_ChipSeq_HeLa-S3_Input_Naked_DNA	Yale_ChipSeq_HeLa-S3_Input_Naked_DNA	GSM935538: Yale_ChipSeq_HeLa-S3_Input_Naked_DNA	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Naked_DNA || control description: Control signal from Naked DNA. || control: Naked_DNA || control description: Control signal from Naked DNA. || controlid: wgEncodeEH000636 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Naked_DNA || control description: Control signal from Naked DNA. || control: Naked_DNA || control description: Control signal from Naked DNA. || controlid: wgEncodeEH000636 || labversion: remapped from hg18 || replicate: 1	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502480	SRX150617	SRS336009	SRP007993	GSM935538	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935538: Yale_ChipSeq_HeLa-S3_Input_Naked_DNA	Yale_ChipSeq_HeLa-S3_Input_Naked_DNA	GSM935538: Yale_ChipSeq_HeLa-S3_Input_Naked_DNA	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Naked_DNA || control description: Control signal from Naked DNA. || control: Naked_DNA || control description: Control signal from Naked DNA. || controlid: wgEncodeEH000636 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Naked_DNA || control description: Control signal from Naked DNA. || control: Naked_DNA || control description: Control signal from Naked DNA. || controlid: wgEncodeEH000636 || labversion: remapped from hg18 || replicate: 1	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502481	SRX150617	SRS336009	SRP007993	GSM935538	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935538: Yale_ChipSeq_HeLa-S3_Input_Naked_DNA	Yale_ChipSeq_HeLa-S3_Input_Naked_DNA	GSM935538: Yale_ChipSeq_HeLa-S3_Input_Naked_DNA	source_name: HeLa-S3 || biomaterial_provider: ATCC || lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Naked_DNA || control description: Control signal from Naked DNA. || control: Naked_DNA || control description: Control signal from Naked DNA. || controlid: wgEncodeEH000636 || labversion: remapped from hg18 || replicate: 1	lab: Yale || lab description: Snyder - Yale University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HeLa-S3 || cell organism: human || cell description: cervical carcinoma || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Naked_DNA || control description: Control signal from Naked DNA. || control: Naked_DNA || control description: Control signal from Naked DNA. || controlid: wgEncodeEH000636 || labversion: remapped from hg18 || replicate: 1	HeLa-S3 -;- cervical carcinoma -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502504	SRX150629	SRS336021	SRP007993	GSM935550	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935550: Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_12hr_Input_std	Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_12hr_Input_std	GSM935550: Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_12hr_Input_std	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: EtOH_0.01pct_12hr || treatment description: 12 h with 0.01% Ethanol (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001869	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: EtOH_0.01pct_12hr || treatment description: 12 h with 0.01% Ethanol (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001869	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	Input	Input	NA	NA	EtOH_0.01pct_12hr -;- 12 h with 0.01% Ethanol (Snyder)	EtOH_0.01pct_12hr
SRR502505	SRX150630	SRS336022	SRP007993	GSM935551	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935551: Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_12hr_STAT3_std	Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_12hr_STAT3_std	GSM935551: Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_12hr_STAT3_std	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: EtOH_0.01pct_12hr || treatment description: 12 h with 0.01% Ethanol (Snyder) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001869 || replicate: 1	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: EtOH_0.01pct_12hr || treatment description: 12 h with 0.01% Ethanol (Snyder) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001869 || replicate: 1	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	STAT3	STAT3	NA	NA	EtOH_0.01pct_12hr -;- 12 h with 0.01% Ethanol (Snyder)	EtOH_0.01pct_12hr
SRR502506	SRX150630	SRS336022	SRP007993	GSM935551	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935551: Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_12hr_STAT3_std	Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_12hr_STAT3_std	GSM935551: Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_12hr_STAT3_std	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: EtOH_0.01pct_12hr || treatment description: 12 h with 0.01% Ethanol (Snyder) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001869 || replicate: 1	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: EtOH_0.01pct_12hr || treatment description: 12 h with 0.01% Ethanol (Snyder) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001869 || replicate: 1	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	STAT3	STAT3	NA	NA	EtOH_0.01pct_12hr -;- 12 h with 0.01% Ethanol (Snyder)	EtOH_0.01pct_12hr
SRR502517	SRX150636	SRS336028	SRP007993	GSM935557	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935557: Stanford_ChipSeq_GM12878_STAT3_IgG-mus	Stanford_ChipSeq_GM12878_STAT3_IgG-mus	GSM935557: Stanford_ChipSeq_GM12878_STAT3_IgG-mus	source_name: GM12878 || biomaterial_provider: Coriell; http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=GM12878 || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000706 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000706 || replicate: 1	GM12878 -;- B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus -;- mesoderm	NA	STAT3	STAT3	NA	NA	None -;- No special treatment or protocol applies	None
SRR502518	SRX150636	SRS336028	SRP007993	GSM935557	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935557: Stanford_ChipSeq_GM12878_STAT3_IgG-mus	Stanford_ChipSeq_GM12878_STAT3_IgG-mus	GSM935557: Stanford_ChipSeq_GM12878_STAT3_IgG-mus	source_name: GM12878 || biomaterial_provider: Coriell; http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=GM12878 || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000706 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000706 || replicate: 1	GM12878 -;- B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus -;- mesoderm	NA	STAT3	STAT3	NA	NA	None -;- No special treatment or protocol applies	None
SRR502531	SRX150643	SRS336035	SRP007993	GSM935564	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935564: Stanford_ChipSeq_GM12878_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM12878_TNFa_Input_IgG-rab	GSM935564: Stanford_ChipSeq_GM12878_TNFa_Input_IgG-rab	source_name: GM12878 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH002034 || labversion: remapped from hg18 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH002034 || labversion: remapped from hg18 || replicate: 1	GM12878 -;- B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus -;- mesoderm	NA	Input	Input	NA	NA	TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	TNFa
SRR502532	SRX150643	SRS336035	SRP007993	GSM935564	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935564: Stanford_ChipSeq_GM12878_TNFa_Input_IgG-rab	Stanford_ChipSeq_GM12878_TNFa_Input_IgG-rab	GSM935564: Stanford_ChipSeq_GM12878_TNFa_Input_IgG-rab	source_name: GM12878 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH002034 || labversion: remapped from hg18 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM12878 || cell organism: human || cell description: B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: TNFa || treatment description: human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder) || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH002034 || labversion: remapped from hg18 || replicate: 1	GM12878 -;- B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus -;- mesoderm	NA	Input	Input	NA	NA	TNFa -;- human recombinant TNF-alpha from eBioscience [product# 14-8329-62] (Snyder)	TNFa
SRR502576	SRX150665	SRS336057	SRP007993	GSM935586	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935586: USC_ChipSeq_HEK293_Input_UCDavis	USC_ChipSeq_HEK293_Input_UCDavis	GSM935586: USC_ChipSeq_HEK293_Input_UCDavis	source_name: HEK293 || biomaterial_provider: ATCC || biomaterial_type: immortalized cell line || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || line: HEK293 || cell organism: human || cell description: embryonic kidney, cells contain Adenovirus 5 DNA (PMID: 11967234) || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001777	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HEK293 || cell organism: human || cell description: embryonic kidney, cells contain Adenovirus 5 DNA (PMID: 11967234) || cell karyotype: normal || cell lineage: mesoderm || cell sex: U || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001777	HEK293 -;- embryonic kidney, cells contain Adenovirus 5 DNA (PMID: 11967234) -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502585	SRX150670	SRS336062	SRP007993	GSM935591	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935591: Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_STAT3_std	Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_STAT3_std	GSM935591: Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_STAT3_std	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: EtOH_0.01pct || treatment description: 36 h with 0.01% Ethanol (Snyder) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001782 || replicate: 1	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: EtOH_0.01pct || treatment description: 36 h with 0.01% Ethanol (Snyder) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001782 || replicate: 1	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	STAT3	STAT3	NA	NA	EtOH_0.01pct -;- 36 h with 0.01% Ethanol (Snyder)	EtOH_0.01pct
SRR502586	SRX150670	SRS336062	SRP007993	GSM935591	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935591: Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_STAT3_std	Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_STAT3_std	GSM935591: Harvard_ChipSeq_MCF10A-Er-Src_EtOH_0.01pct_STAT3_std	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: EtOH_0.01pct || treatment description: 36 h with 0.01% Ethanol (Snyder) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001782 || replicate: 1	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: EtOH_0.01pct || treatment description: 36 h with 0.01% Ethanol (Snyder) || antibody: STAT3 || antibody antibodydescription: Rabbit polyclonal; epitope mapping at the C-terminus of Stat3 of mouse origin. Antibody Target: STAT3 || antibody targetdescription: Member of STAT family. After phosphorylation in response to cytokines and growth factors (including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2), forms homo- or heterodimers that translocate to nucleus and activate transcription. Activates expression of a variety of genes with roles in processes such as cell growth and apoptosis. || antibody vendorname: Santa Cruz Biotech || antibody vendorid: sc-482 || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001782 || replicate: 1	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	STAT3	STAT3	NA	NA	EtOH_0.01pct -;- 36 h with 0.01% Ethanol (Snyder)	EtOH_0.01pct
SRR502589	SRX150672	SRS336064	SRP007993	GSM935593	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935593: USC_ChipSeq_PBDE_Input_UCDavis	USC_ChipSeq_PBDE_Input_UCDavis	GSM935593: USC_ChipSeq_PBDE_Input_UCDavis	source_name: PBDE || biomaterial_provider: Farnham lab || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: PBDE || cell organism: human || cell description: peripheral blood-derived erythroblasts || cell lineage: mesoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001778	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: PBDE || cell organism: human || cell description: peripheral blood-derived erythroblasts || cell lineage: mesoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH001778	PBDE -;- peripheral blood-derived erythroblasts -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502606	SRX150680	SRS336072	SRP007993	GSM935601	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935601: USC_ChipSeq_K562_Input_UCDavis	USC_ChipSeq_K562_Input_UCDavis	GSM935601: USC_ChipSeq_K562_Input_UCDavis	source_name: K562 || biomaterial_provider: ATCC || biomaterial_type: immortalized cell line || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || line: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH000672 || labversion: Illumina 2.0, low confidence sequences excluded	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH000672 || labversion: Illumina 2.0, low confidence sequences excluded	K562 -;- leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502611	SRX150683	SRS336075	SRP007993	GSM935604	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935604: Stanford_ChipSeq_HepG2_Input_IgG-rab	Stanford_ChipSeq_HepG2_Input_IgG-rab	GSM935604: Stanford_ChipSeq_HepG2_Input_IgG-rab	source_name: HepG2 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH001791	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: HepG2 || cell organism: human || cell description: hepatocellular carcinoma || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH001791	HepG2 -;- hepatocellular carcinoma -;- endoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502612	SRX150684	SRS336076	SRP007993	GSM935605	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935605: Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	GSM935605: Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502613	SRX150684	SRS336076	SRP007993	GSM935605	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935605: Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	GSM935605: Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502614	SRX150684	SRS336076	SRP007993	GSM935605	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935605: Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	GSM935605: Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502615	SRX150684	SRS336076	SRP007993	GSM935605	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935605: Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	GSM935605: Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502616	SRX150684	SRS336076	SRP007993	GSM935605	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935605: Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	GSM935605: Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502617	SRX150684	SRS336076	SRP007993	GSM935605	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935605: Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	GSM935605: Harvard_ChipSeq_MCF10A-Er-Src_Input_Harvard_Control	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: Harvard_Control || control description: input library was prepared at Harvard. || control: Harvard_Control || control description: input library was prepared at Harvard. || controlid: wgEncodeEH002871 || replicate: 1	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502620	SRX150686	SRS336078	SRP007993	GSM935607	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935607: USC_ChipSeq_GM08714_Input_UCDavis	USC_ChipSeq_GM08714_Input_UCDavis	GSM935607: USC_ChipSeq_GM08714_Input_UCDavis	source_name: GM08714 || biomaterial_provider: Coriell || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM08714 || cell organism: human || cell description: lymphoblastoid cell line, Instability of heterochromatin of chromosomes 1, 9, and 16 with variable combined immunodeficiency; dysmorphic facial features, developmental delay, malabsorption, and recurrent infections; see GM08747 Fibroblast; donor subject is a compound heterozygote: one allele has a G>A transition at nucleotide 1807 (1807G>A) of the DNMT3B gene resulting in an Ala to Thr substitution at codon 603 [Ala603Thr (A603T)], the mutation occurring in a region between motifs I and IV within the catalytic domain of DNMT3B; the second allele has a G>A transition within intron 22 located 11 nucleotides 5-prime of the normal splice acceptor site [IVS22AS,G>A,-11] resulting in the generation of a novel splice acceptor site and a 9-bp insertion in the processed RNA. This results in the insertion of 3 amino acids (serine, threonine, and proline) at codon 744 (744ins3). The insertion was within the conserved region of the catalytic domain, which is likely to be disrupted by the insertion of a proline residue. This mutation was de novo. || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH002870 || replicate: 1	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM08714 || cell organism: human || cell description: lymphoblastoid cell line, Instability of heterochromatin of chromosomes 1, 9, and 16 with variable combined immunodeficiency; dysmorphic facial features, developmental delay, malabsorption, and recurrent infections; see GM08747 Fibroblast; donor subject is a compound heterozygote: one allele has a G>A transition at nucleotide 1807 (1807G>A) of the DNMT3B gene resulting in an Ala to Thr substitution at codon 603 [Ala603Thr (A603T)], the mutation occurring in a region between motifs I and IV within the catalytic domain of DNMT3B; the second allele has a G>A transition within intron 22 located 11 nucleotides 5-prime of the normal splice acceptor site [IVS22AS,G>A,-11] resulting in the generation of a novel splice acceptor site and a 9-bp insertion in the processed RNA. This results in the insertion of 3 amino acids (serine, threonine, and proline) at codon 744 (744ins3). The insertion was within the conserved region of the catalytic domain, which is likely to be disrupted by the insertion of a proline residue. This mutation was de novo. || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH002870 || replicate: 1	GM08714 -;- lymphoblastoid cell line, Instability of heterochromatin of chromosomes 1, 9, and 16 with variable combined immunodeficiency; dysmorphic facial features, developmental delay, malabsorption, and recurrent infections; see GM08747 Fibroblast; donor subject is a compound heterozygote: one allele has a G>A transition at nucleotide 1807 (1807G>A) of the DNMT3B gene resulting in an Ala to Thr substitution at codon 603 [Ala603Thr (A603T)], the mutation occurring in a region between motifs I and IV within the catalytic domain of DNMT3B; the second allele has a G>A transition within intron 22 located 11 nucleotides 5-prime of the normal splice acceptor site [IVS22AS,G>A,-11] resulting in the generation of a novel splice acceptor site and a 9-bp insertion in the processed RNA. This results in the insertion of 3 amino acids (serine, threonine, and proline) at codon 744 (744ins3). The insertion was within the conserved region of the catalytic domain, which is likely to be disrupted by the insertion of a proline residue. This mutation was de novo. -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502621	SRX150686	SRS336078	SRP007993	GSM935607	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935607: USC_ChipSeq_GM08714_Input_UCDavis	USC_ChipSeq_GM08714_Input_UCDavis	GSM935607: USC_ChipSeq_GM08714_Input_UCDavis	source_name: GM08714 || biomaterial_provider: Coriell || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM08714 || cell organism: human || cell description: lymphoblastoid cell line, Instability of heterochromatin of chromosomes 1, 9, and 16 with variable combined immunodeficiency; dysmorphic facial features, developmental delay, malabsorption, and recurrent infections; see GM08747 Fibroblast; donor subject is a compound heterozygote: one allele has a G>A transition at nucleotide 1807 (1807G>A) of the DNMT3B gene resulting in an Ala to Thr substitution at codon 603 [Ala603Thr (A603T)], the mutation occurring in a region between motifs I and IV within the catalytic domain of DNMT3B; the second allele has a G>A transition within intron 22 located 11 nucleotides 5-prime of the normal splice acceptor site [IVS22AS,G>A,-11] resulting in the generation of a novel splice acceptor site and a 9-bp insertion in the processed RNA. This results in the insertion of 3 amino acids (serine, threonine, and proline) at codon 744 (744ins3). The insertion was within the conserved region of the catalytic domain, which is likely to be disrupted by the insertion of a proline residue. This mutation was de novo. || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH002870 || replicate: 1	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM08714 || cell organism: human || cell description: lymphoblastoid cell line, Instability of heterochromatin of chromosomes 1, 9, and 16 with variable combined immunodeficiency; dysmorphic facial features, developmental delay, malabsorption, and recurrent infections; see GM08747 Fibroblast; donor subject is a compound heterozygote: one allele has a G>A transition at nucleotide 1807 (1807G>A) of the DNMT3B gene resulting in an Ala to Thr substitution at codon 603 [Ala603Thr (A603T)], the mutation occurring in a region between motifs I and IV within the catalytic domain of DNMT3B; the second allele has a G>A transition within intron 22 located 11 nucleotides 5-prime of the normal splice acceptor site [IVS22AS,G>A,-11] resulting in the generation of a novel splice acceptor site and a 9-bp insertion in the processed RNA. This results in the insertion of 3 amino acids (serine, threonine, and proline) at codon 744 (744ins3). The insertion was within the conserved region of the catalytic domain, which is likely to be disrupted by the insertion of a proline residue. This mutation was de novo. || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH002870 || replicate: 1	GM08714 -;- lymphoblastoid cell line, Instability of heterochromatin of chromosomes 1, 9, and 16 with variable combined immunodeficiency; dysmorphic facial features, developmental delay, malabsorption, and recurrent infections; see GM08747 Fibroblast; donor subject is a compound heterozygote: one allele has a G>A transition at nucleotide 1807 (1807G>A) of the DNMT3B gene resulting in an Ala to Thr substitution at codon 603 [Ala603Thr (A603T)], the mutation occurring in a region between motifs I and IV within the catalytic domain of DNMT3B; the second allele has a G>A transition within intron 22 located 11 nucleotides 5-prime of the normal splice acceptor site [IVS22AS,G>A,-11] resulting in the generation of a novel splice acceptor site and a 9-bp insertion in the processed RNA. This results in the insertion of 3 amino acids (serine, threonine, and proline) at codon 744 (744ins3). The insertion was within the conserved region of the catalytic domain, which is likely to be disrupted by the insertion of a proline residue. This mutation was de novo. -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502640	SRX150696	SRS336088	SRP007993	GSM935617	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935617: USC_ChipSeq_PANC-1_Input_UCDavis	USC_ChipSeq_PANC-1_Input_UCDavis	GSM935617: USC_ChipSeq_PANC-1_Input_UCDavis	source_name: PANC-1 || biomaterial_provider: ATCC || biomaterial_type: immortalized cell line || lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || line: PANC-1 || cell organism: human || cell description: pancreatic carcinoma, (PMID: 1140870) PANC-1 was established from a pancreatic carcinoma, which was extracted via pancreatico-duodenectomy specimen from a 56-year-old Caucasian individual. Malignancy of this cell line was verified via in vitro and in vivo assays. || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH002070 || replicate: 1	lab: USC || lab description: Farnham - University of Southern California || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: PANC-1 || cell organism: human || cell description: pancreatic carcinoma, (PMID: 1140870) PANC-1 was established from a pancreatic carcinoma, which was extracted via pancreatico-duodenectomy specimen from a 56-year-old Caucasian individual. Malignancy of this cell line was verified via in vitro and in vivo assays. || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: UCDavis || control description: Input library was prepared at UC Davis. || control: UCDavis || control description: Input library was prepared at UC Davis. || controlid: wgEncodeEH002070 || replicate: 1	PANC-1 -;- pancreatic carcinoma, (PMID: 1140870) PANC-1 was established from a pancreatic carcinoma, which was extracted via pancreatico-duodenectomy specimen from a 56-year-old Caucasian individual. Malignancy of this cell line was verified via in vitro and in vivo assays. -;- endoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502641	SRX150697	SRS336089	SRP007993	GSM935618	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935618: Stanford_ChipSeq_K562_Input_IgG-rab	Stanford_ChipSeq_K562_Input_IgG-rab	GSM935618: Stanford_ChipSeq_K562_Input_IgG-rab	source_name: K562 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH001795	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH001795	K562 -;- leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502663	SRX150708	SRS336100	SRP007993	GSM935629	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935629: Stanford_ChipSeq_A549_Input_IgG-rab	Stanford_ChipSeq_A549_Input_IgG-rab	GSM935629: Stanford_ChipSeq_A549_Input_IgG-rab	source_name: A549 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: A549 || cell organism: human || cell description: epithelial cell line derived from a lung carcinoma tissue. (PMID: 175022), "This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old caucasian male." - ATCC, newly promoted to tier 2: not in 2011 analysis || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH002819 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: A549 || cell organism: human || cell description: epithelial cell line derived from a lung carcinoma tissue. (PMID: 175022), "This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old caucasian male." - ATCC, newly promoted to tier 2: not in 2011 analysis || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH002819 || replicate: 1	A549 -;- epithelial cell line derived from a lung carcinoma tissue. (PMID: 175022), "This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old caucasian male." - ATCC, newly promoted to tier 2: not in 2011 analysis -;- endoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502664	SRX150708	SRS336100	SRP007993	GSM935629	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935629: Stanford_ChipSeq_A549_Input_IgG-rab	Stanford_ChipSeq_A549_Input_IgG-rab	GSM935629: Stanford_ChipSeq_A549_Input_IgG-rab	source_name: A549 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: A549 || cell organism: human || cell description: epithelial cell line derived from a lung carcinoma tissue. (PMID: 175022), "This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old caucasian male." - ATCC, newly promoted to tier 2: not in 2011 analysis || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH002819 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: A549 || cell organism: human || cell description: epithelial cell line derived from a lung carcinoma tissue. (PMID: 175022), "This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old caucasian male." - ATCC, newly promoted to tier 2: not in 2011 analysis || cell karyotype: cancer || cell lineage: endoderm || cell sex: M || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH002819 || replicate: 1	A549 -;- epithelial cell line derived from a lung carcinoma tissue. (PMID: 175022), "This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old caucasian male." - ATCC, newly promoted to tier 2: not in 2011 analysis -;- endoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502667	SRX150710	SRS336102	SRP007993	GSM935631	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935631: Stanford_ChipSeq_K562_Input_IgG-mus	Stanford_ChipSeq_K562_Input_IgG-mus	GSM935631: Stanford_ChipSeq_K562_Input_IgG-mus	source_name: K562 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000726 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000726 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	K562 -;- leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502668	SRX150710	SRS336102	SRP007993	GSM935631	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935631: Stanford_ChipSeq_K562_Input_IgG-mus	Stanford_ChipSeq_K562_Input_IgG-mus	GSM935631: Stanford_ChipSeq_K562_Input_IgG-mus	source_name: K562 || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000726 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: K562 || cell organism: human || cell description: leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC || cell karyotype: cancer || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000726 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	K562 -;- leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC -;- mesoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR502686	SRX150718	SRS336110	SRP007993	GSM935639	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935639: Stanford_ChipSeq_GM10847_Input_IgG-mus	Stanford_ChipSeq_GM10847_Input_IgG-mus	GSM935639: Stanford_ChipSeq_GM10847_Input_IgG-mus	source_name: GM10847 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM10847 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000728 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM10847 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000728 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM10847 -;- lymphoblastoid, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR502687	SRX150718	SRS336110	SRP007993	GSM935639	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935639: Stanford_ChipSeq_GM10847_Input_IgG-mus	Stanford_ChipSeq_GM10847_Input_IgG-mus	GSM935639: Stanford_ChipSeq_GM10847_Input_IgG-mus	source_name: GM10847 || biomaterial_provider: Coriell || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM10847 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000728 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: GM10847 || cell organism: human || cell description: lymphoblastoid, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed || cell karyotype: normal || cell lineage: mesoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || control: IgG-mus || control description: Input signal from Normal Mouse IgG ChIP-seq. || controlid: wgEncodeEH000728 || labversion: Illumina 2.0, low confidence sequences excluded || replicate: 1	GM10847 -;- lymphoblastoid, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed -;- mesoderm	NA	Input	Input	NA	NA	Epstein-Barr Virus transformed -;- None -;- No special treatment or protocol applies	Epstein-Barr Virus transformed -;- None
SRR502691	SRX150720	SRS336112	SRP007993	GSM935641	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM935641: Harvard_ChipSeq_MCF10A-Er-Src_Input_std	Harvard_ChipSeq_MCF10A-Er-Src_Input_std	GSM935641: Harvard_ChipSeq_MCF10A-Er-Src_Input_std	source_name: MCF10A-Er-Src || biomaterial_provider: Struhl laboratory || lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001782	lab: Harvard || lab description: Struhl - Harvard University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: MCF10A-Er-Src || cell organism: human || cell description: mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) || cell karyotype: normal || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: std || control description: Standard input signal for most experiments. || control: std || control description: Standard input signal for most experiments. || controlid: wgEncodeEH001782	MCF10A-Er-Src -;- mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER) -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR568166	SRX186629	SRS362697	SRP007993	GSM1003624	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM1003624: Stanford_ChipSeq_SK-N-SH_Input_IgG-rab	Stanford_ChipSeq_SK-N-SH_Input_IgG-rab	GSM1003624: Stanford_ChipSeq_SK-N-SH_Input_IgG-rab	source_name: SK-N-SH || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: SK-N-SH || cell organism: human || cell description: neuroblastoma, newly promoted to tier 2: not in 2011 analysis, the SK-N-SH line was established from a neuroblastoma in a 4 year old individual. || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH003393 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: SK-N-SH || cell organism: human || cell description: neuroblastoma, newly promoted to tier 2: not in 2011 analysis, the SK-N-SH line was established from a neuroblastoma in a 4 year old individual. || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH003393 || replicate: 1	SK-N-SH -;- neuroblastoma, newly promoted to tier 2: not in 2011 analysis, the SK-N-SH line was established from a neuroblastoma in a 4 year old individual. -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR568167	SRX186629	SRS362697	SRP007993	GSM1003624	GSE31477	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	GSM1003624: Stanford_ChipSeq_SK-N-SH_Input_IgG-rab	Stanford_ChipSeq_SK-N-SH_Input_IgG-rab	GSM1003624: Stanford_ChipSeq_SK-N-SH_Input_IgG-rab	source_name: SK-N-SH || biomaterial_provider: ATCC || lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: SK-N-SH || cell organism: human || cell description: neuroblastoma, newly promoted to tier 2: not in 2011 analysis, the SK-N-SH line was established from a neuroblastoma in a 4 year old individual. || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH003393 || replicate: 1	lab: Stanford || lab description: Snyder - Stanford University || datatype: ChipSeq || datatype description: Chromatin IP Sequencing || cell: SK-N-SH || cell organism: human || cell description: neuroblastoma, newly promoted to tier 2: not in 2011 analysis, the SK-N-SH line was established from a neuroblastoma in a 4 year old individual. || cell karyotype: cancer || cell lineage: ectoderm || cell sex: F || treatment: None || treatment description: No special treatment or protocol applies || antibody: Input || antibody description: Control signal which may be subtracted from experimental raw signal before peaks are called. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || control: IgG-rab || control description: Input signal from Normal Rabbit IgG ChIP-seq. || controlid: wgEncodeEH003393 || replicate: 1	SK-N-SH -;- neuroblastoma, newly promoted to tier 2: not in 2011 analysis, the SK-N-SH line was established from a neuroblastoma in a 4 year old individual. -;- ectoderm	NA	Input	Input	NA	NA	None -;- No special treatment or protocol applies	None
SRR414680	SRX122475	SRS295360	SRP011071	GSM881118	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881118: ChIP-Seq of Stat3 0 min post LPS stimulation	ChIP-Seq of Stat3 0 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881118_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 0 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 0 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414681	SRX122475	SRS295360	SRP011071	GSM881118	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881118: ChIP-Seq of Stat3 0 min post LPS stimulation	ChIP-Seq of Stat3 0 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881118_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 0 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 0 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414682	SRX122475	SRS295360	SRP011071	GSM881118	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881118: ChIP-Seq of Stat3 0 min post LPS stimulation	ChIP-Seq of Stat3 0 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881118_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 0 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 0 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414683	SRX122475	SRS295360	SRP011071	GSM881118	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881118: ChIP-Seq of Stat3 0 min post LPS stimulation	ChIP-Seq of Stat3 0 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881118_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 0 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 0 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414684	SRX122476	SRS295361	SRP011071	GSM881119	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881119: ChIP-Seq of Stat3 120 min post LPS stimulation	ChIP-Seq of Stat3 120 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881119_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 120 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 120 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414685	SRX122476	SRS295361	SRP011071	GSM881119	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881119: ChIP-Seq of Stat3 120 min post LPS stimulation	ChIP-Seq of Stat3 120 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881119_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 120 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 120 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414686	SRX122476	SRS295361	SRP011071	GSM881119	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881119: ChIP-Seq of Stat3 120 min post LPS stimulation	ChIP-Seq of Stat3 120 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881119_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 120 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 120 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414687	SRX122476	SRS295361	SRP011071	GSM881119	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881119: ChIP-Seq of Stat3 120 min post LPS stimulation	ChIP-Seq of Stat3 120 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881119_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 120 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 120 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414688	SRX122477	SRS295362	SRP011071	GSM881120	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881120: ChIP-Seq of Stat3 30 min post LPS stimulation	ChIP-Seq of Stat3 30 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881120_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 30 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 30 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414689	SRX122477	SRS295362	SRP011071	GSM881120	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881120: ChIP-Seq of Stat3 30 min post LPS stimulation	ChIP-Seq of Stat3 30 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881120_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 30 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 30 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414690	SRX122477	SRS295362	SRP011071	GSM881120	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881120: ChIP-Seq of Stat3 30 min post LPS stimulation	ChIP-Seq of Stat3 30 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881120_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 30 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 30 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414691	SRX122477	SRS295362	SRP011071	GSM881120	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881120: ChIP-Seq of Stat3 30 min post LPS stimulation	ChIP-Seq of Stat3 30 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881120_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 30 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 30 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414692	SRX122478	SRS295363	SRP011071	GSM881121	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881121: ChIP-Seq of Stat3 60 min post LPS stimulation	ChIP-Seq of Stat3 60 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881121_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 60 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 60 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414693	SRX122478	SRS295363	SRP011071	GSM881121	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881121: ChIP-Seq of Stat3 60 min post LPS stimulation	ChIP-Seq of Stat3 60 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881121_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 60 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 60 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414694	SRX122478	SRS295363	SRP011071	GSM881121	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881121: ChIP-Seq of Stat3 60 min post LPS stimulation	ChIP-Seq of Stat3 60 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881121_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 60 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 60 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414695	SRX122478	SRS295363	SRP011071	GSM881121	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881121: ChIP-Seq of Stat3 60 min post LPS stimulation	ChIP-Seq of Stat3 60 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881121_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 60 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: Stat3 || treatment: LPS || time: 60 min || chip antibody manufacturer: Bethyl || chip antibody catalog number: A302-406A	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	Stat3	Stat3	NA	NA	LPS	LPS
SRR414696	SRX122479	SRS295364	SRP011071	GSM881122	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881122: ChIP-Seq of WCE 0 min post LPS stimulation	ChIP-Seq of WCE 0 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881122_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414697	SRX122479	SRS295364	SRP011071	GSM881122	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881122: ChIP-Seq of WCE 0 min post LPS stimulation	ChIP-Seq of WCE 0 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881122_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414698	SRX122479	SRS295364	SRP011071	GSM881122	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881122: ChIP-Seq of WCE 0 min post LPS stimulation	ChIP-Seq of WCE 0 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881122_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414699	SRX122479	SRS295364	SRP011071	GSM881122	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881122: ChIP-Seq of WCE 0 min post LPS stimulation	ChIP-Seq of WCE 0 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881122_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414700	SRX122479	SRS295364	SRP011071	GSM881122	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881122: ChIP-Seq of WCE 0 min post LPS stimulation	ChIP-Seq of WCE 0 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881122_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414701	SRX122479	SRS295364	SRP011071	GSM881122	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881122: ChIP-Seq of WCE 0 min post LPS stimulation	ChIP-Seq of WCE 0 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881122_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414702	SRX122479	SRS295364	SRP011071	GSM881122	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881122: ChIP-Seq of WCE 0 min post LPS stimulation	ChIP-Seq of WCE 0 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881122_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414703	SRX122479	SRS295364	SRP011071	GSM881122	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881122: ChIP-Seq of WCE 0 min post LPS stimulation	ChIP-Seq of WCE 0 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881122_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 0 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414704	SRX122480	SRS295365	SRP011071	GSM881123	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881123: ChIP-Seq of WCE 120 min post LPS stimulation	ChIP-Seq of WCE 120 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881123_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414705	SRX122480	SRS295365	SRP011071	GSM881123	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881123: ChIP-Seq of WCE 120 min post LPS stimulation	ChIP-Seq of WCE 120 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881123_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414706	SRX122480	SRS295365	SRP011071	GSM881123	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881123: ChIP-Seq of WCE 120 min post LPS stimulation	ChIP-Seq of WCE 120 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881123_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414707	SRX122480	SRS295365	SRP011071	GSM881123	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881123: ChIP-Seq of WCE 120 min post LPS stimulation	ChIP-Seq of WCE 120 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881123_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414708	SRX122480	SRS295365	SRP011071	GSM881123	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881123: ChIP-Seq of WCE 120 min post LPS stimulation	ChIP-Seq of WCE 120 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881123_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414709	SRX122480	SRS295365	SRP011071	GSM881123	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881123: ChIP-Seq of WCE 120 min post LPS stimulation	ChIP-Seq of WCE 120 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881123_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414710	SRX122480	SRS295365	SRP011071	GSM881123	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881123: ChIP-Seq of WCE 120 min post LPS stimulation	ChIP-Seq of WCE 120 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881123_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414711	SRX122480	SRS295365	SRP011071	GSM881123	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881123: ChIP-Seq of WCE 120 min post LPS stimulation	ChIP-Seq of WCE 120 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881123_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 120 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414712	SRX122481	SRS295366	SRP011071	GSM881124	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881124: ChIP-Seq of WCE 30 min post LPS stimulation	ChIP-Seq of WCE 30 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881124_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414713	SRX122481	SRS295366	SRP011071	GSM881124	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881124: ChIP-Seq of WCE 30 min post LPS stimulation	ChIP-Seq of WCE 30 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881124_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414714	SRX122481	SRS295366	SRP011071	GSM881124	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881124: ChIP-Seq of WCE 30 min post LPS stimulation	ChIP-Seq of WCE 30 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881124_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414715	SRX122481	SRS295366	SRP011071	GSM881124	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881124: ChIP-Seq of WCE 30 min post LPS stimulation	ChIP-Seq of WCE 30 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881124_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414716	SRX122481	SRS295366	SRP011071	GSM881124	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881124: ChIP-Seq of WCE 30 min post LPS stimulation	ChIP-Seq of WCE 30 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881124_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414717	SRX122481	SRS295366	SRP011071	GSM881124	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881124: ChIP-Seq of WCE 30 min post LPS stimulation	ChIP-Seq of WCE 30 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881124_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414718	SRX122481	SRS295366	SRP011071	GSM881124	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881124: ChIP-Seq of WCE 30 min post LPS stimulation	ChIP-Seq of WCE 30 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881124_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414719	SRX122481	SRS295366	SRP011071	GSM881124	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881124: ChIP-Seq of WCE 30 min post LPS stimulation	ChIP-Seq of WCE 30 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881124_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 30 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414720	SRX122482	SRS295367	SRP011071	GSM881125	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881125: ChIP-Seq of WCE 60 min post LPS stimulation	ChIP-Seq of WCE 60 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881125_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414721	SRX122482	SRS295367	SRP011071	GSM881125	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881125: ChIP-Seq of WCE 60 min post LPS stimulation	ChIP-Seq of WCE 60 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881125_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414722	SRX122482	SRS295367	SRP011071	GSM881125	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881125: ChIP-Seq of WCE 60 min post LPS stimulation	ChIP-Seq of WCE 60 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881125_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414723	SRX122482	SRS295367	SRP011071	GSM881125	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881125: ChIP-Seq of WCE 60 min post LPS stimulation	ChIP-Seq of WCE 60 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881125_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414724	SRX122482	SRS295367	SRP011071	GSM881125	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881125: ChIP-Seq of WCE 60 min post LPS stimulation	ChIP-Seq of WCE 60 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881125_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414725	SRX122482	SRS295367	SRP011071	GSM881125	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881125: ChIP-Seq of WCE 60 min post LPS stimulation	ChIP-Seq of WCE 60 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881125_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414726	SRX122482	SRS295367	SRP011071	GSM881125	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881125: ChIP-Seq of WCE 60 min post LPS stimulation	ChIP-Seq of WCE 60 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881125_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR414727	SRX122482	SRS295367	SRP011071	GSM881125	GSE36099,GSE36104	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM881125: ChIP-Seq of WCE 60 min post LPS stimulation	ChIP-Seq of WCE 60 min post LPS stimulation; Mus musculus; ChIP-Seq	GSM881125_1	source_name: bone marrow || cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	cell type: bone marrow-derived dendritic cells || strain: C57BL/6 || chip antibody: none || treatment: LPS || time: 60 min || chip antibody manufacturer: none || chip antibody catalog number: none	C57BL/6 -;- bone marrow -;- bone marrow-derived dendritic cells	bone marrow-derived dendritic cells	none	none	NA	NA	LPS	LPS
SRR493724	SRX145797	SRS311993	SRP012641	GSM926623	GSE37235	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM926623: Control IgG	Control IgG; Mus musculus; ChIP-Seq	GSM926623_1	source_name: AtT-20 corticotroph cells treated with Control IgG || cell line: AtT-20 || cell type: pituitary corticotroph cell || treatment: LIF, Dex+LIF, Dex (control pooled from different experiments) || chip antibody: rabbit IgG (G2018, Sigma)	cell line: AtT-20 || cell type: pituitary corticotroph cell || treatment: LIF, Dex+LIF, Dex (control pooled from different experiments) || chip antibody: rabbit IgG (G2018, Sigma)	AtT-20 corticotroph cells treated with Control IgG -;- pituitary corticotroph cell	pituitary corticotroph cell -;- AtT-20	rabbit IgG (G2018, Sigma)	rabbit IgG (G2018, Sigma)	NA	NA	LIF, Dex+LIF, Dex (control pooled from different experiments)	LIF, Dex+LIF, Dex (control pooled from different experiments)
SRR493725	SRX145797	SRS311993	SRP012641	GSM926623	GSE37235	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM926623: Control IgG	Control IgG; Mus musculus; ChIP-Seq	GSM926623_1	source_name: AtT-20 corticotroph cells treated with Control IgG || cell line: AtT-20 || cell type: pituitary corticotroph cell || treatment: LIF, Dex+LIF, Dex (control pooled from different experiments) || chip antibody: rabbit IgG (G2018, Sigma)	cell line: AtT-20 || cell type: pituitary corticotroph cell || treatment: LIF, Dex+LIF, Dex (control pooled from different experiments) || chip antibody: rabbit IgG (G2018, Sigma)	AtT-20 corticotroph cells treated with Control IgG -;- pituitary corticotroph cell	pituitary corticotroph cell -;- AtT-20	rabbit IgG (G2018, Sigma)	rabbit IgG (G2018, Sigma)	NA	NA	LIF, Dex+LIF, Dex (control pooled from different experiments)	LIF, Dex+LIF, Dex (control pooled from different experiments)
SRR493726	SRX145798	SRS311994	SRP012641	GSM926624	GSE37235	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM926624: Stat3 (LIF)	Stat3 (LIF); Mus musculus; ChIP-Seq	GSM926624_1	source_name: AtT-20 corticotroph cells treated with Stat3 (LIF) || cell line: AtT-20 || cell type: pituitary corticotroph cell || treatment: LIF || chip antibody: p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	cell line: AtT-20 || cell type: pituitary corticotroph cell || treatment: LIF || chip antibody: p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	AtT-20 corticotroph cells treated with Stat3 (LIF) -;- pituitary corticotroph cell	pituitary corticotroph cell -;- AtT-20	p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	NA	NA	LIF	LIF
SRR493727	SRX145798	SRS311994	SRP012641	GSM926624	GSE37235	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM926624: Stat3 (LIF)	Stat3 (LIF); Mus musculus; ChIP-Seq	GSM926624_1	source_name: AtT-20 corticotroph cells treated with Stat3 (LIF) || cell line: AtT-20 || cell type: pituitary corticotroph cell || treatment: LIF || chip antibody: p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	cell line: AtT-20 || cell type: pituitary corticotroph cell || treatment: LIF || chip antibody: p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	AtT-20 corticotroph cells treated with Stat3 (LIF) -;- pituitary corticotroph cell	pituitary corticotroph cell -;- AtT-20	p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	NA	NA	LIF	LIF
SRR493728	SRX145799	SRS311995	SRP012641	GSM926625	GSE37235	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM926625: Stat3 (Dex+LIF)	Stat3 (Dex+LIF); Mus musculus; ChIP-Seq	GSM926625_1	source_name: AtT-20 corticotroph cells treated with Stat3 (Dex+LIF) || cell line: AtT-20 || cell type: pituitary corticotroph cell || treatment: Dex+LIF || chip antibody: p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	cell line: AtT-20 || cell type: pituitary corticotroph cell || treatment: Dex+LIF || chip antibody: p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	AtT-20 corticotroph cells treated with Stat3 (Dex+LIF) -;- pituitary corticotroph cell	pituitary corticotroph cell -;- AtT-20	p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	NA	NA	Dex+LIF	Dex+LIF
SRR493729	SRX145799	SRS311995	SRP012641	GSM926625	GSE37235	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM926625: Stat3 (Dex+LIF)	Stat3 (Dex+LIF); Mus musculus; ChIP-Seq	GSM926625_1	source_name: AtT-20 corticotroph cells treated with Stat3 (Dex+LIF) || cell line: AtT-20 || cell type: pituitary corticotroph cell || treatment: Dex+LIF || chip antibody: p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	cell line: AtT-20 || cell type: pituitary corticotroph cell || treatment: Dex+LIF || chip antibody: p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	AtT-20 corticotroph cells treated with Stat3 (Dex+LIF) -;- pituitary corticotroph cell	pituitary corticotroph cell -;- AtT-20	p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	NA	NA	Dex+LIF	Dex+LIF
SRR493730	SRX145799	SRS311995	SRP012641	GSM926625	GSE37235	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM926625: Stat3 (Dex+LIF)	Stat3 (Dex+LIF); Mus musculus; ChIP-Seq	GSM926625_1	source_name: AtT-20 corticotroph cells treated with Stat3 (Dex+LIF) || cell line: AtT-20 || cell type: pituitary corticotroph cell || treatment: Dex+LIF || chip antibody: p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	cell line: AtT-20 || cell type: pituitary corticotroph cell || treatment: Dex+LIF || chip antibody: p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	AtT-20 corticotroph cells treated with Stat3 (Dex+LIF) -;- pituitary corticotroph cell	pituitary corticotroph cell -;- AtT-20	p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	p-STAT3 (sc-7993) and STAT3 (sc-482x) from SantaCruz	NA	NA	Dex+LIF	Dex+LIF
ERR1088408	ERX1167962	ERS939112	ERP012882	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	E-MTAB-3954:IgG_HPC7	Illumina HiSeq 1000 sequencing; Transcriptional binding patterns involved in promoter-enhancer interactions.	E-MTAB-3954:IgG_HPC7	isolate: not applicable || organism: Mus musculus || cell line: HPC-7 || sequencing type: Hi-C sequencing || cell type: haematopoietic stem/progenitor cell	NA	not applicable -;- haematopoietic stem/progenitor cell -;- HPC-7	NA	NA	NA	NA	NA	NA	NA
ERR1088417	ERX1167971	ERS939121	ERP012882	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	E-MTAB-3954:Stat3_HPC7	Illumina HiSeq 1000 sequencing; Transcriptional binding patterns involved in promoter-enhancer interactions.	E-MTAB-3954:Stat3_HPC7	isolate: not applicable || organism: Mus musculus || cell line: HPC-7 || sequencing type: Hi-C sequencing || cell type: haematopoietic stem/progenitor cell	NA	not applicable -;- haematopoietic stem/progenitor cell -;- HPC-7	NA	NA	NA	NA	NA	NA	NA
SRR529936	SRX172322	SRS352374	SRP014628	GSM978746	GSE39756	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM978746: WT Bcell IgG	WT Bcell IgG; Mus musculus; ChIP-Seq	GSM978746_1	source_name: B cells || strain: C57BL/6 || cell type: B cells || tissue: Spleen || chip antibody: Rabbit IgG (R&D, AB-105-C, ER11)	strain: C57BL/6 || cell type: B cells || tissue: Spleen || chip antibody: Rabbit IgG (R&D, AB-105-C, ER11)	C57BL/6 -;- Spleen -;- B cells	Spleen -;- B cells	Rabbit IgG (R&D, AB-105-C, ER11)	Rabbit IgG (R&D, AB-105-C, ER11)	NA	NA	NA	NA
SRR529939	SRX172325	SRS352378	SRP014628	GSM978749	GSE39756	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM978749: WT CD4 T IgG	WT CD4 T IgG; Mus musculus; ChIP-Seq	GSM978749_1	source_name: CD4+ T Cells || strain: C57BL/6 || cell type: CD4+ T Cells || tissue: Spleen || chip antibody: Rabbit IgG (R&D, AB-105-C, ER11)	strain: C57BL/6 || cell type: CD4+ T Cells || tissue: Spleen || chip antibody: Rabbit IgG (R&D, AB-105-C, ER11)	C57BL/6 -;- Spleen -;- CD4+ T Cells	Spleen -;- CD4+ T Cells	Rabbit IgG (R&D, AB-105-C, ER11)	Rabbit IgG (R&D, AB-105-C, ER11)	NA	NA	NA	NA
SRR529946	SRX172332	SRS352385	SRP014628	GSM978756	GSE39756	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM978756: WT CD4 T -IL21 STAT3	WT CD4 T -IL21 STAT3; Mus musculus; ChIP-Seq	GSM978756_1	source_name: CD4+ T Cells || strain: C57BL/6 || cell type: CD4+ T Cells || tissue: Spleen || chip antibody: STAT3 (Invitrogen, 13-7000)	strain: C57BL/6 || cell type: CD4+ T Cells || tissue: Spleen || chip antibody: STAT3 (Invitrogen, 13-7000)	C57BL/6 -;- Spleen -;- CD4+ T Cells	Spleen -;- CD4+ T Cells	STAT3 (Invitrogen, 13-7000)	STAT3 (Invitrogen, 13-7000)	NA	NA	NA	NA
SRR529947	SRX172333	SRS352386	SRP014628	GSM978757	GSE39756	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM978757: WT CD4 T +IL21 STAT3	WT CD4 T +IL21 STAT3; Mus musculus; ChIP-Seq	GSM978757_1	source_name: CD4+ T Cells || strain: C57BL/6 || cell type: CD4+ T Cells || tissue: Spleen || chip antibody: STAT3 (Invitrogen, 13-7000)	strain: C57BL/6 || cell type: CD4+ T Cells || tissue: Spleen || chip antibody: STAT3 (Invitrogen, 13-7000)	C57BL/6 -;- Spleen -;- CD4+ T Cells	Spleen -;- CD4+ T Cells	STAT3 (Invitrogen, 13-7000)	STAT3 (Invitrogen, 13-7000)	NA	NA	NA	NA
SRR529956	SRX172342	SRS352395	SRP014628	GSM978766	GSE39756	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM978766: Th17 IgG	Th17 IgG; Mus musculus; ChIP-Seq	GSM978766_1	source_name: Th17 Cells || strain: C57BL/6 || cell type: Th17 Cells || tissue: Spleen || chip antibody: Rabbit IgG (R&D, AB-105-C, ER11)	strain: C57BL/6 || cell type: Th17 Cells || tissue: Spleen || chip antibody: Rabbit IgG (R&D, AB-105-C, ER11)	C57BL/6 -;- Spleen -;- Th17 Cells	Spleen -;- Th17 Cells	Rabbit IgG (R&D, AB-105-C, ER11)	Rabbit IgG (R&D, AB-105-C, ER11)	NA	NA	NA	NA
SRR529962	SRX172348	SRS352400	SRP014628	GSM978772	GSE39756	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM978772: Th17 Stat3	Th17 Stat3; Mus musculus; ChIP-Seq	GSM978772_1	source_name: Th17 Cells || strain: C57BL/6 || cell type: Th17 Cells || tissue: Spleen || chip antibody: STAT3 (Invitrogen, 13-7000)	strain: C57BL/6 || cell type: Th17 Cells || tissue: Spleen || chip antibody: STAT3 (Invitrogen, 13-7000)	C57BL/6 -;- Spleen -;- Th17 Cells	Spleen -;- Th17 Cells	STAT3 (Invitrogen, 13-7000)	STAT3 (Invitrogen, 13-7000)	NA	NA	NA	NA
SRR571544	SRX187189	SRS363448	SRP015773	GSM1004784	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004784	SL3039; Mus musculus; ChIP-Seq	GSM1004784_1	source_name: Th0 in vitro || genotype: wt || control: SL3038 || factor: B-ATF || application: ChIP-Seq || cell type: Th0	genotype: wt || control: SL3038 || factor: B-ATF || application: ChIP-Seq || cell type: Th0	Th0 in vitro	Th0	NA	NA	wt	wt	NA	NA
SRR571545	SRX187190	SRS363449	SRP015773	GSM1004785	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004785	SL3192; Mus musculus; ChIP-Seq	GSM1004785_1	source_name: Th0 in vitro || genotype: wt || control: SL3190 || factor: B-ATF || application: ChIP-Seq || cell type: Th0	genotype: wt || control: SL3190 || factor: B-ATF || application: ChIP-Seq || cell type: Th0	Th0 in vitro	Th0	NA	NA	wt	wt	NA	NA
SRR571546	SRX187191	SRS363450	SRP015773	GSM1004786	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004786	SL3033; Mus musculus; ChIP-Seq	GSM1004786_1	source_name: Th17 in vitro || genotype: wt || control: SL3036 || factor: B-ATF || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL3036 || factor: B-ATF || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571549	SRX187194	SRS363453	SRP015773	GSM1004789	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004789	SL8348; Mus musculus; ChIP-Seq	GSM1004789_1	source_name: Th0 in vitro || genotype: IRF4 wt || control: SL8356 || factor: Batf || time_point: 48h || application: ChIP-Seq || cell type: Th0	genotype: IRF4 wt || control: SL8356 || factor: Batf || time_point: 48h || application: ChIP-Seq || cell type: Th0	Th0 in vitro	Th0	NA	NA	IRF4 wt	IRF4 wt	NA	NA
SRR571550	SRX187195	SRS363454	SRP015773	GSM1004790	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004790	SL8350; Mus musculus; ChIP-Seq	GSM1004790_1	source_name: Th0 in vitro || genotype: IRF4 ko || control: SL8346 || factor: Batf || time_point: 48h || application: ChIP-Seq || cell type: Th0	genotype: IRF4 ko || control: SL8346 || factor: Batf || time_point: 48h || application: ChIP-Seq || cell type: Th0	Th0 in vitro	Th0	NA	NA	IRF4 ko	IRF4 ko	NA	NA
SRR571553	SRX187198	SRS363457	SRP015773	GSM1004793	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004793	SL10570; Mus musculus; ChIP-Seq	GSM1004793_1	source_name: Th17 in vitro || genotype: wt || control: SL10564 || factor: BATF || time_point: 16h || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL10564 || factor: BATF || time_point: 16h || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571554	SRX187199	SRS363458	SRP015773	GSM1004794	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004794	SL8349; Mus musculus; ChIP-Seq	GSM1004794_1	source_name: Th17 in vitro || genotype: IRF4 wt || control: SL8357 || factor: Batf || time_point: 48h || application: ChIP-Seq || cell type: Th17	genotype: IRF4 wt || control: SL8357 || factor: Batf || time_point: 48h || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	IRF4 wt	IRF4 wt	NA	NA
SRR571555	SRX187200	SRS363459	SRP015773	GSM1004795	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004795	SL8351; Mus musculus; ChIP-Seq	GSM1004795_1	source_name: Th17 in vitro || genotype: IRF4 ko || control: SL8347 || factor: Batf || time_point: 48h || application: ChIP-Seq || cell type: Th17	genotype: IRF4 ko || control: SL8347 || factor: Batf || time_point: 48h || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	IRF4 ko	IRF4 ko	NA	NA
SRR571556	SRX187201	SRS363460	SRP015773	GSM1004796	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004796	SL9449; Mus musculus; ChIP-Seq	GSM1004796_1	source_name: Th17 in vitro || genotype: IRF4 wt || control: SL9445 || factor: Batf || time_point: 48h || application: ChIP-Seq || cell type: Th17	genotype: IRF4 wt || control: SL9445 || factor: Batf || time_point: 48h || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	IRF4 wt	IRF4 wt	NA	NA
SRR571557	SRX187202	SRS363461	SRP015773	GSM1004797	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004797	SL9451; Mus musculus; ChIP-Seq	GSM1004797_1	source_name: Th17 in vitro || genotype: IRF4 ko || control: SL9447 || factor: Batf || time_point: 48h || application: ChIP-Seq || cell type: Th17	genotype: IRF4 ko || control: SL9447 || factor: Batf || time_point: 48h || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	IRF4 ko	IRF4 ko	NA	NA
SRR571562	SRX187207	SRS363466	SRP015773	GSM1004802	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004802	SL3191; Mus musculus; ChIP-Seq	GSM1004802_1	source_name: Th0 in vitro || genotype: wt || control: SL3190 || factor: CTCF || application: ChIP-Seq || cell type: Th0	genotype: wt || control: SL3190 || factor: CTCF || application: ChIP-Seq || cell type: Th0	Th0 in vitro	Th0	NA	NA	wt	wt	NA	NA
SRR571563	SRX187208	SRS363467	SRP015773	GSM1004803	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004803	SL3781; Mus musculus; ChIP-Seq	GSM1004803_1	source_name: Th0 in vitro || genotype: wt || control: SL3778 || factor: CTCF || application: ChIP-Seq || cell type: Th0	genotype: wt || control: SL3778 || factor: CTCF || application: ChIP-Seq || cell type: Th0	Th0 in vitro	Th0	NA	NA	wt	wt	NA	NA
SRR571564	SRX187209	SRS363468	SRP015773	GSM1004804	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004804	SL3034; Mus musculus; ChIP-Seq	GSM1004804_1	source_name: Th17 in vitro || genotype: wt || control: SL3035 || factor: CTCF || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL3035 || factor: CTCF || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571565	SRX187210	SRS363469	SRP015773	GSM1004805	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004805	SL3783; Mus musculus; ChIP-Seq	GSM1004805_1	source_name: Th17 in vitro || genotype: wt || control: SL3782 || factor: CTCF || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL3782 || factor: CTCF || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571566	SRX187211	SRS363470	SRP015773	GSM1004806	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004806	SL10573; Mus musculus; ChIP-Seq	GSM1004806_1	source_name: Th17 in vitro || genotype: wt || control: SL10567 || factor: Etv6 || time_point: 48h || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL10567 || factor: Etv6 || time_point: 48h || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571567	SRX187212	SRS363471	SRP015773	GSM1004807	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004807	SL13368; Mus musculus; ChIP-Seq	GSM1004807_1	source_name: Th17 in vitro || genotype: wt || control: SL13364 || factor: Etv6 || time_point: 48h || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL13364 || factor: Etv6 || time_point: 48h || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571568	SRX187213	SRS363472	SRP015773	GSM1004808	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004808	SL6500; Mus musculus; ChIP-Seq	GSM1004808_1	source_name: Th0 in vitro || genotype: wt || control: SL6499 || factor: Fosl2 || application: ChIP-Seq || cell type: Th0	genotype: wt || control: SL6499 || factor: Fosl2 || application: ChIP-Seq || cell type: Th0	Th0 in vitro	Th0	NA	NA	wt	wt	NA	NA
SRR571569	SRX187214	SRS363473	SRP015773	GSM1004809	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004809	SL6498; Mus musculus; ChIP-Seq	GSM1004809_1	source_name: Th17 in vitro || genotype: wt || control: SL6497 || factor: Fosl2 || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL6497 || factor: Fosl2 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571570	SRX187215	SRS363474	SRP015773	GSM1004810	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004810	SL6625; Mus musculus; ChIP-Seq	GSM1004810_1	source_name: Th17 in vitro || genotype: wt || control: SL6627 || factor: Fosl2 || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL6627 || factor: Fosl2 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571571	SRX187216	SRS363475	SRP015773	GSM1004811	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004811	SL2991; Mus musculus; ChIP-Seq	GSM1004811_1	source_name: Th17 in vitro || genotype: RORg wt || control: SL2999 || factor: H3K4me2 || application: ChIP-Seq || cell type: Th17	genotype: RORg wt || control: SL2999 || factor: H3K4me2 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg wt	RORg wt	NA	NA
SRR571572	SRX187217	SRS363476	SRP015773	GSM1004812	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004812	SL2992; Mus musculus; ChIP-Seq	GSM1004812_1	source_name: Th17 in vitro || genotype: RORg ko || control: SL3000 || factor: H3K4me2 || application: ChIP-Seq || cell type: Th17	genotype: RORg ko || control: SL3000 || factor: H3K4me2 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg ko	RORg ko	NA	NA
SRR571573	SRX187218	SRS363477	SRP015773	GSM1004813	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004813	SL4032; Mus musculus; ChIP-Seq	GSM1004813_1	source_name: Th17 in vitro || genotype: RORg wt || control: SL4028 || factor: H3K4me2 || application: ChIP-Seq || cell type: Th17	genotype: RORg wt || control: SL4028 || factor: H3K4me2 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg wt	RORg wt	NA	NA
SRR571574	SRX187219	SRS363478	SRP015773	GSM1004814	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004814	SL4033; Mus musculus; ChIP-Seq	GSM1004814_1	source_name: Th17 in vitro || genotype: RORg ko || control: SL4029 || factor: H3K4me2 || application: ChIP-Seq || cell type: Th17	genotype: RORg ko || control: SL4029 || factor: H3K4me2 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg ko	RORg ko	NA	NA
SRR571575	SRX187220	SRS363479	SRP015773	GSM1004815	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004815	SL2993; Mus musculus; ChIP-Seq	GSM1004815_1	source_name: Th17 in vitro || genotype: RORg wt || control: SL2999 || factor: H3K4me3 || application: ChIP-Seq || cell type: Th17	genotype: RORg wt || control: SL2999 || factor: H3K4me3 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg wt	RORg wt	NA	NA
SRR571576	SRX187221	SRS363480	SRP015773	GSM1004816	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004816	SL2994; Mus musculus; ChIP-Seq	GSM1004816_1	source_name: Th17 in vitro || genotype: RORg ko || control: SL3000 || factor: H3K4me3 || application: ChIP-Seq || cell type: Th17	genotype: RORg ko || control: SL3000 || factor: H3K4me3 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg ko	RORg ko	NA	NA
SRR571577	SRX187222	SRS363481	SRP015773	GSM1004817	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004817	SL4034; Mus musculus; ChIP-Seq	GSM1004817_1	source_name: Th17 in vitro || genotype: RORg wt || control: SL4028 || factor: H3K4me3 || application: ChIP-Seq || cell type: Th17	genotype: RORg wt || control: SL4028 || factor: H3K4me3 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg wt	RORg wt	NA	NA
SRR571578	SRX187223	SRS363482	SRP015773	GSM1004818	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004818	SL4035; Mus musculus; ChIP-Seq	GSM1004818_1	source_name: Th17 in vitro || genotype: RORg ko || control: SL4029 || factor: H3K4me3 || application: ChIP-Seq || cell type: Th17	genotype: RORg ko || control: SL4029 || factor: H3K4me3 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg ko	RORg ko	NA	NA
SRR571579	SRX187224	SRS363483	SRP015773	GSM1004819	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004819	SL10572; Mus musculus; ChIP-Seq	GSM1004819_1	source_name: Th17 in vitro || genotype: wt || control: SL10566 || factor: Hif1a || time_point: 48h || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL10566 || factor: Hif1a || time_point: 48h || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571580	SRX187225	SRS363484	SRP015773	GSM1004820	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004820	SL10575; Mus musculus; ChIP-Seq	GSM1004820_1	source_name: Th17 in vitro || genotype: wt || control: SL10569 || factor: Hif1a || time_point: 48h || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL10569 || factor: Hif1a || time_point: 48h || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571584	SRX187229	SRS363488	SRP015773	GSM1004824	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004824	SL1235; Mus musculus; ChIP-Seq	GSM1004824_1	source_name: Th0 in vitro || genotype: wt || control: SL1234 || factor: IRF4 || application: ChIP-Seq || cell type: Th0	genotype: wt || control: SL1234 || factor: IRF4 || application: ChIP-Seq || cell type: Th0	Th0 in vitro	Th0	NA	NA	wt	wt	NA	NA
SRR571585	SRX187230	SRS363489	SRP015773	GSM1004825	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004825	SL6632; Mus musculus; ChIP-Seq	GSM1004825_1	source_name: Th0 in vitro || genotype: Batf wt || control: SL6634 || factor: IRF4 || application: ChIP-Seq || cell type: Th0	genotype: Batf wt || control: SL6634 || factor: IRF4 || application: ChIP-Seq || cell type: Th0	Th0 in vitro	Th0	NA	NA	Batf wt	Batf wt	NA	NA
SRR571586	SRX187231	SRS363490	SRP015773	GSM1004826	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004826	SL6633; Mus musculus; ChIP-Seq	GSM1004826_1	source_name: Th0 in vitro || genotype: Batf ko || control: SL6635 || factor: IRF4 || application: ChIP-Seq || cell type: Th0	genotype: Batf ko || control: SL6635 || factor: IRF4 || application: ChIP-Seq || cell type: Th0	Th0 in vitro	Th0	NA	NA	Batf ko	Batf ko	NA	NA
SRR571587	SRX187232	SRS363491	SRP015773	GSM1004827	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004827	SL9855; Mus musculus; ChIP-Seq	GSM1004827_1	source_name: Th17 in vitro || genotype: wt || control: SL9859 || factor: IRF4 || time_point: 16h || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL9859 || factor: IRF4 || time_point: 16h || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571592	SRX187237	SRS363496	SRP015773	GSM1004832	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004832	SL1046; Mus musculus; ChIP-Seq	GSM1004832_1	source_name: Th17 in vitro || genotype: IRF4 ko || control: SL1045 || factor: IRF4 || application: ChIP-Seq || cell type: Th17	genotype: IRF4 ko || control: SL1045 || factor: IRF4 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	IRF4 ko	IRF4 ko	NA	NA
SRR571593	SRX187238	SRS363497	SRP015773	GSM1004833	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004833	SL2872; Mus musculus; ChIP-Seq	GSM1004833_1	source_name: Th17 in vitro || genotype: RORg wt || control: SL2876 || factor: IRF4 || application: ChIP-Seq || cell type: Th17	genotype: RORg wt || control: SL2876 || factor: IRF4 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg wt	RORg wt	NA	NA
SRR571594	SRX187239	SRS363498	SRP015773	GSM1004834	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004834	SL2873; Mus musculus; ChIP-Seq	GSM1004834_1	source_name: Th17 in vitro || genotype: RORg ko || control: SL2877 || factor: IRF4 || application: ChIP-Seq || cell type: Th17	genotype: RORg ko || control: SL2877 || factor: IRF4 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg ko	RORg ko	NA	NA
SRR571595	SRX187240	SRS363499	SRP015773	GSM1004835	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004835	SL3317; Mus musculus; ChIP-Seq	GSM1004835_1	source_name: Th17 in vitro || genotype: RORg wt || control: SL3319 || factor: IRF4 || application: ChIP-Seq || cell type: Th17	genotype: RORg wt || control: SL3319 || factor: IRF4 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg wt	RORg wt	NA	NA
SRR571599	SRX187244	SRS363503	SRP015773	GSM1004839	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004839	SL12384; Mus musculus; ChIP-Seq	GSM1004839_1	source_name: Th17 in vitro || genotype: wt || control: SL12382 || factor: Jmjd3 || time_point: 48h || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL12382 || factor: Jmjd3 || time_point: 48h || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571600	SRX187245	SRS363504	SRP015773	GSM1004840	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004840	SL12386; Mus musculus; ChIP-Seq	GSM1004840_1	source_name: Th17 in vitro || genotype: wt || control: SL12382 || factor: Jmjd6 || time_point: 48h || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL12382 || factor: Jmjd6 || time_point: 48h || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571603	SRX187248	SRS363507	SRP015773	GSM1004843	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004843	SL13866; Mus musculus; ChIP-Seq	GSM1004843_1	source_name: Th17 in vitro || genotype: Stat3 +/+ CD4-Cre || control: SL13864 || factor: p300 || time_point: 48h || application: ChIP-Seq || cell type: Th17	genotype: Stat3 +/+ CD4-Cre || control: SL13864 || factor: p300 || time_point: 48h || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	Stat3 +/+ CD4-Cre	Stat3 +/+ CD4-Cre	NA	NA
SRR571604	SRX187249	SRS363508	SRP015773	GSM1004844	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004844	SL13867; Mus musculus; ChIP-Seq	GSM1004844_1	source_name: Th17 in vitro || genotype: Stat3 fl/fl CD4-Cre || control: SL13865 || factor: p300 || time_point: 48h || application: ChIP-Seq || cell type: Th17	genotype: Stat3 fl/fl CD4-Cre || control: SL13865 || factor: p300 || time_point: 48h || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	Stat3 fl/fl CD4-Cre	Stat3 fl/fl CD4-Cre	NA	NA
SRR571609	SRX187254	SRS363513	SRP015773	GSM1004849	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004849	SL1041; Mus musculus; ChIP-Seq	GSM1004849_1	source_name: Th17 in vitro || genotype: wt || control: SL972 || factor: p300 || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL972 || factor: p300 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571612	SRX187257	SRS363516	SRP015773	GSM1004852	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004852	SL3595; Mus musculus; ChIP-Seq	GSM1004852_1	source_name: Th17 in vitro || genotype: RORg ko || control: SL3593 || factor: p300 || application: ChIP-Seq || cell type: Th17	genotype: RORg ko || control: SL3593 || factor: p300 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg ko	RORg ko	NA	NA
SRR571616	SRX187261	SRS363520	SRP015773	GSM1004856	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004856	SL2870; Mus musculus; ChIP-Seq	GSM1004856_1	source_name: Th17 in vitro || genotype: wt || control: SL2871 || factor: RORg || application: ChIP-Seq || cell type: Th17	genotype: wt || control: SL2871 || factor: RORg || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	wt	wt	NA	NA
SRR571622	SRX187267	SRS363526	SRP015773	GSM1004862	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004862	SL1239; Mus musculus; ChIP-Seq	GSM1004862_1	source_name: Th17 in vitro || genotype: STAT3 ko || control: SL1238 || factor: STAT3 || application: ChIP-Seq || cell type: Th17	genotype: STAT3 ko || control: SL1238 || factor: STAT3 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	STAT3 ko	STAT3 ko	NA	NA
SRR571623	SRX187268	SRS363527	SRP015773	GSM1004863	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004863	SL2874; Mus musculus; ChIP-Seq	GSM1004863_1	source_name: Th17 in vitro || genotype: RORg wt || control: SL2876 || factor: STAT3 || application: ChIP-Seq || cell type: Th17	genotype: RORg wt || control: SL2876 || factor: STAT3 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg wt	RORg wt	NA	NA
SRR571624	SRX187269	SRS363528	SRP015773	GSM1004864	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004864	SL2875; Mus musculus; ChIP-Seq	GSM1004864_1	source_name: Th17 in vitro || genotype: RORg ko || control: SL2877 || factor: STAT3 || application: ChIP-Seq || cell type: Th17	genotype: RORg ko || control: SL2877 || factor: STAT3 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg ko	RORg ko	NA	NA
SRR571625	SRX187270	SRS363529	SRP015773	GSM1004865	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004865	SL3315; Mus musculus; ChIP-Seq	GSM1004865_1	source_name: Th17 in vitro || genotype: RORg wt || control: SL3319 || factor: STAT3 || application: ChIP-Seq || cell type: Th17	genotype: RORg wt || control: SL3319 || factor: STAT3 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg wt	RORg wt	NA	NA
SRR571626	SRX187271	SRS363530	SRP015773	GSM1004866	GSE40918	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	GSM1004866	SL3316; Mus musculus; ChIP-Seq	GSM1004866_1	source_name: Th17 in vitro || genotype: RORg ko || control: SL3320 || factor: STAT3 || application: ChIP-Seq || cell type: Th17	genotype: RORg ko || control: SL3320 || factor: STAT3 || application: ChIP-Seq || cell type: Th17	Th17 in vitro	Th17	NA	NA	RORg ko	RORg ko	NA	NA
SRR952594	SRX335317	SRS470436	SRP028819	GSM1208799	GSE49402	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	batch2_chrom1_LoVo_STAT3_Mouse_FailedQC; Homo sapiens; ChIP-Seq	GSM1208799	source_name: LoVo || cell line: LoVo || cell type: colon adenocarcinoma || qc successful: FailedQC	cell line: LoVo || cell type: colon adenocarcinoma || enriched motif (p<0.001) with dbd sequence similarity > 65%.: NA || qc successful: FailedQC	LoVo -;- colon adenocarcinoma	colon adenocarcinoma -;- LoVo	NA	NA	NA	NA	NA	NA
SRR952607	SRX335330	SRS470449	SRP028819	GSM1208812	GSE49402	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	batch1_chrom1_LoVo_IgG_Mouse; Homo sapiens; ChIP-Seq	GSM1208812	source_name: LoVo || cell line: LoVo || cell type: colon adenocarcinoma || qc successful: NA	cell line: LoVo || cell type: colon adenocarcinoma || enriched motif (p<0.001) with dbd sequence similarity > 65%.: NA || qc successful: NA	LoVo -;- colon adenocarcinoma	colon adenocarcinoma -;- LoVo	NA	NA	NA	NA	NA	NA
SRR952608	SRX335331	SRS470450	SRP028819	GSM1208813	GSE49402	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	batch1_chrom1_LoVo_IgG_Rabbit; Homo sapiens; ChIP-Seq	GSM1208813	source_name: LoVo || cell line: LoVo || cell type: colon adenocarcinoma || qc successful: NA	cell line: LoVo || cell type: colon adenocarcinoma || enriched motif (p<0.001) with dbd sequence similarity > 65%.: NA || qc successful: NA	LoVo -;- colon adenocarcinoma	colon adenocarcinoma -;- LoVo	NA	NA	NA	NA	NA	NA
SRR952609	SRX335332	SRS470451	SRP028819	GSM1208814	GSE49402	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	batch1_chrom1_LoVo_IgG_Goat; Homo sapiens; ChIP-Seq	GSM1208814	source_name: LoVo || cell line: LoVo || cell type: colon adenocarcinoma || qc successful: NA	cell line: LoVo || cell type: colon adenocarcinoma || enriched motif (p<0.001) with dbd sequence similarity > 65%.: NA || qc successful: NA	LoVo -;- colon adenocarcinoma	colon adenocarcinoma -;- LoVo	NA	NA	NA	NA	NA	NA
SRR1561946	SRX690232	SRS692751	SRP045911	GSM1494453	GSE60955	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	STAT3i 6hr H3K27me3 ChIP-seq, rep 1; Homo sapiens; ChIP-Seq	GSM1494453	source_name: embryonic stem cell || cell line: ELF embryonic stem cell || pluripotency state: naÃƒÂ¯ve || treatment: STAT3 inhibitor 6h || chip antibody: anti-H3K27me3 (Active Motif, catalog# 39155, lot# 26611010)	cell line: ELF embryonic stem cell || pluripotency state: naïve || treatment: STAT3 inhibitor 6h || chip antibody: anti-H3K27me3 (Active Motif, catalog# 39155, lot# 26611010)	embryonic stem cell -;- ELF embryonic stem cell	ELF embryonic stem cell	anti-H3K27me3 (Active Motif, catalog# 39155, lot# 26611010)	anti-H3K27me3 (Active Motif, catalog# 39155, lot# 26611010)	NA	NA	STAT3 inhibitor 6h	STAT3 inhibitor 6h
SRR1561947	SRX690233	SRS692752	SRP045911	GSM1494454	GSE60955	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	input for STAT3i 6hr H3K27me3, rep 1; Homo sapiens; ChIP-Seq	GSM1494454	source_name: embryonic stem cell || cell line: ELF embryonic stem cell || pluripotency state: naÃƒÂ¯ve || treatment: STAT3 inhibitor 6h || chip antibody: none	cell line: ELF embryonic stem cell || pluripotency state: naïve || treatment: STAT3 inhibitor 6h || chip antibody: none	embryonic stem cell -;- ELF embryonic stem cell	ELF embryonic stem cell	none	none	NA	NA	STAT3 inhibitor 6h	STAT3 inhibitor 6h
SRR1561949	SRX690235	SRS692753	SRP045911	GSM1494456	GSE60955	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	input for ELF H3K27me3 ChIP-seq; Homo sapiens; ChIP-Seq	GSM1494456	source_name: embryonic stem cell || cell line: ELF embryonic stem cell || pluripotency state: naÃƒÂ¯ve || treatment: none || chip antibody: none	cell line: ELF embryonic stem cell || pluripotency state: naïve || treatment: none || chip antibody: none	embryonic stem cell -;- ELF embryonic stem cell	ELF embryonic stem cell	none	none	NA	NA	none	none
SRR1576417	SRX702120	SRS701985	SRP047193	GSM1505779	GSE61475	ChIP-Seq	ILLUMINA	PAIRED - 	true	9606	NA	STAT3 MNChIP-seq in cell type dEN Stat3_070213_endo; Homo sapiens;       ChIP-Seq	GSM1505779	source_name: dEN || cell line: HUES64 || cell type: dEN || chip antibody: STAT3(Cell Signaling,4904BF,4)	cell line: HUES64 || cell type: dEN || chip antibody: STAT3(Cell Signaling,4904BF,4)	dEN -;- HUES64	dEN -;- HUES64	STAT3(Cell Signaling,4904BF,4)	STAT3(Cell Signaling,4904BF,4)	NA	NA	NA	NA
SRR1576418	SRX702121	SRS701986	SRP047193	GSM1505780	GSE61475	ChIP-Seq	ILLUMINA	PAIRED - 	true	9606	NA	STAT3 MNChIP-seq in cell type dME Stat3_070213_meso; Homo sapiens;       ChIP-Seq	GSM1505780	source_name: dME || cell line: HUES64 || cell type: dME || chip antibody: STAT3(Cell Signaling,4904BF,4)	cell line: HUES64 || cell type: dME || chip antibody: STAT3(Cell Signaling,4904BF,4)	dME -;- HUES64	dME -;- HUES64	STAT3(Cell Signaling,4904BF,4)	STAT3(Cell Signaling,4904BF,4)	NA	NA	NA	NA
SRR1576419	SRX702122	SRS701987	SRP047193	GSM1505781	GSE61475	ChIP-Seq	ILLUMINA	PAIRED - 	true	9606	NA	STAT3 MNChIP-seq in cell type HUES64 Stat3_cs_070213_h64; Homo sapiens;       ChIP-Seq	GSM1505781	source_name: HUES64 || cell line: HUES64 || cell type: HUES64 || chip antibody: STAT3(Cell Signaling,4904BF,4)	cell line: HUES64 || cell type: HUES64 || chip antibody: STAT3(Cell Signaling,4904BF,4)	HUES64	HUES64	STAT3(Cell Signaling,4904BF,4)	STAT3(Cell Signaling,4904BF,4)	NA	NA	NA	NA
SRR1576440	SRX702143	SRS702007	SRP047193	GSM1505802	GSE61475	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	WCE (Mnase treated) in cell type HUES64 WCE-M15_070512_h64; Homo sapiens; ChIP-Seq	GSM1505802	source_name: HUES64 || cell line: HUES64 || cell type: HUES64 || chip antibody: NA	cell line: HUES64 || cell type: HUES64 || chip antibody: NA	HUES64	HUES64	NA	NA	NA	NA	NA	NA
SRR1576441	SRX702144	SRS702008	SRP047193	GSM1505803	GSE61475	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	WCE (Mnase treated) in cell type HUES64 WCE-M19_070912_h64; Homo sapiens; ChIP-Seq	GSM1505803	source_name: HUES64 || cell line: HUES64 || cell type: HUES64 || chip antibody: NA	cell line: HUES64 || cell type: HUES64 || chip antibody: NA	HUES64	HUES64	NA	NA	NA	NA	NA	NA
SRR1576443	SRX702146	SRS702010	SRP047193	GSM1505805	GSE61475	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	WCE (sonicated) in cell type dME WCE_072712_meso; Homo sapiens; ChIP-Seq	GSM1505805	source_name: dME || cell line: HUES64 || cell type: dME || chip antibody: NA	cell line: HUES64 || cell type: dME || chip antibody: NA	dME -;- HUES64	dME -;- HUES64	NA	NA	NA	NA	NA	NA
SRR1576442	SRX702145	SRS702011	SRP047193	GSM1505804	GSE61475	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	WCE (sonicated) in cell type HUES64 WCE_072712_h64; Homo sapiens; ChIP-Seq	GSM1505804	source_name: HUES64 || cell line: HUES64 || cell type: HUES64 || chip antibody: NA	cell line: HUES64 || cell type: HUES64 || chip antibody: NA	HUES64	HUES64	NA	NA	NA	NA	NA	NA
SRR1583910	SRX708755	SRS707823	SRP047424	GSM1511213	GSE61677	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	WT CD4 T -IL21 STAT3; Mus musculus; ChIP-Seq	GSM1511213	source_name: Pre-activated CD4+ T cells || strain: C57BL/6 || tissue: Spleen || cell type: Pre-activated CD4+ T cells || treated with: none (untreated) || chip antibody: STAT3 || chip antibody vendor: Invitrogen	strain: C57BL/6 || tissue: Spleen || cell type: Pre-activated CD4+ T cells || treated with: none (untreated) || chip antibody: STAT3 || chip antibody vendor: Invitrogen || chip antibody cat.#: 13-7000	C57BL/6 -;- Spleen -;- Pre-activated CD4+ T cells	Spleen -;- Pre-activated CD4+ T cells	STAT3	STAT3	NA	NA	none (untreated)	NA
SRR1583911	SRX708756	SRS707824	SRP047424	GSM1511214	GSE61677	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	WT CD4 T +IL21 STAT3; Mus musculus; ChIP-Seq	GSM1511214	source_name: Pre-activated CD4+ T cells || strain: C57BL/6 || tissue: Spleen || cell type: Pre-activated CD4+ T cells || treated with: IL-21 for 1h || chip antibody: STAT3 || chip antibody vendor: Invitrogen	strain: C57BL/6 || tissue: Spleen || cell type: Pre-activated CD4+ T cells || treated with: IL-21 for 1h || chip antibody: STAT3 || chip antibody vendor: Invitrogen || chip antibody cat.#: 13-7000	C57BL/6 -;- Spleen -;- Pre-activated CD4+ T cells	Spleen -;- Pre-activated CD4+ T cells	STAT3	STAT3	NA	NA	IL-21 for 1h	NA
SRR1583920	SRX708765	SRS707833	SRP047424	GSM1511223	GSE61677	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	WT DC T -IL21 STAT3; Mus musculus; ChIP-Seq	GSM1511223	source_name: Splenic conventional dendritic Cells || strain: C57BL/6 || tissue: Spleen || cell type: Splenic conventional dendritic Cells || treated with: none (untreated) || chip antibody: STAT3 || chip antibody vendor: Invitrogen	strain: C57BL/6 || tissue: Spleen || cell type: Splenic conventional dendritic Cells || treated with: none (untreated) || chip antibody: STAT3 || chip antibody vendor: Invitrogen || chip antibody cat.#: 13-7000	C57BL/6 -;- Spleen -;- Splenic conventional dendritic Cells	Spleen -;- Splenic conventional dendritic Cells	STAT3	STAT3	NA	NA	none (untreated)	NA
SRR1583921	SRX708766	SRS707834	SRP047424	GSM1511224	GSE61677	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	WT DC T +IL21 STAT3; Mus musculus; ChIP-Seq	GSM1511224	source_name: Splenic conventional dendritic Cells || strain: C57BL/6 || tissue: Spleen || cell type: Splenic conventional dendritic Cells || treated with: IL-21 for 1h || chip antibody: STAT3 || chip antibody vendor: Invitrogen	strain: C57BL/6 || tissue: Spleen || cell type: Splenic conventional dendritic Cells || treated with: IL-21 for 1h || chip antibody: STAT3 || chip antibody vendor: Invitrogen || chip antibody cat.#: 13-7000	C57BL/6 -;- Spleen -;- Splenic conventional dendritic Cells	Spleen -;- Splenic conventional dendritic Cells	STAT3	STAT3	NA	NA	IL-21 for 1h	NA
SRR2570629	SRX1310633	SRS1103375	SRP050434	GSM1903798	GSE63778	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	Th17_Input; Mus musculus; ChIP-Seq	GSM1903798	source_name: primary T cells || strain: C57BL/6 || cell type: primary T cells || chip-antibody: none	strain: C57BL/6 || cell type: primary T cells || chip-antibody: none	C57BL/6 -;- primary T cells	primary T cells	none	none	NA	NA	NA	NA
SRR1688279	SRX793127	SRS776914	SRP050434	GSM1557002	GSE63778	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	Th17_Input_group1; Mus musculus; ChIP-Seq	GSM1557002	source_name: primary T cells || strain: C57BL/6 || chip-antibody: none || cell type: primary T cells	strain: C57BL/6 || chip-antibody: none || cell type: primary T cells	C57BL/6 -;- primary T cells	primary T cells	none	none	NA	NA	NA	NA
SRR1688281	SRX793129	SRS776916	SRP050434	GSM1557004	GSE63778	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	Th17_Stat3KO_Brd4_ChIP-seq_group2; Mus musculus; ChIP-Seq	GSM1557004	source_name: primary T cells || strain: C57BL/6 || chip-antibody: Brd4 (Bethyl; IHC-00396) || cell type: primary T cells	strain: C57BL/6 || chip-antibody: Brd4 (Bethyl; IHC-00396) || cell type: primary T cells	C57BL/6 -;- primary T cells	primary T cells	Brd4 (Bethyl; IHC-00396)	Brd4 (Bethyl; IHC-00396)	NA	NA	NA	NA
SRR1688282	SRX793130	SRS776917	SRP050434	GSM1557005	GSE63778	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	Th17_Input_group2; Mus musculus; ChIP-Seq	GSM1557005	source_name: primary T cells || strain: C57BL/6 || chip-antibody: none || cell type: primary T cells	strain: C57BL/6 || chip-antibody: none || cell type: primary T cells	C57BL/6 -;- primary T cells	primary T cells	none	none	NA	NA	NA	NA
SRR1736528	SRX825177	SRS804744	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq STAT3 tamoxifen 4 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: 4-hydroxytamoxifen 04hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	4-hydroxytamoxifen 04hrs	NA
SRR1736529	SRX825177	SRS804744	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq STAT3 tamoxifen 4 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: 4-hydroxytamoxifen 04hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	4-hydroxytamoxifen 04hrs	NA
SRR1736534	SRX825297	SRS804744	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq INPUT tamoxifen 4 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: 4-hydroxytamoxifen 04hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	4-hydroxytamoxifen 04hrs	NA
SRR1736537	SRX825181	SRS804745	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq STAT3 tamoxifen 12 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: 4-hydroxytamoxifen 12hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	4-hydroxytamoxifen 12hrs	NA
SRR1736539	SRX825181	SRS804745	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq STAT3 tamoxifen 12 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: 4-hydroxytamoxifen 12hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	4-hydroxytamoxifen 12hrs	NA
SRR1736542	SRX825299	SRS804745	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq INPUT tamoxifen 12 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: 4-hydroxytamoxifen 12hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	4-hydroxytamoxifen 12hrs	NA
SRR1736545	SRX825185	SRS804747	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq STAT3 tamoxifen 36 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: 4-hydroxytamoxifen 36hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	4-hydroxytamoxifen 36hrs	NA
SRR1736546	SRX825185	SRS804747	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq STAT3 tamoxifen 36 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: 4-hydroxytamoxifen 36hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	4-hydroxytamoxifen 36hrs	NA
SRR1736547	SRX825301	SRS804747	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq INPUT tamoxifen 36 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: 4-hydroxytamoxifen 36hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	4-hydroxytamoxifen 36hrs	NA
SRR1736591	SRX825190	SRS804750	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq STAT3 tamoxifen 4 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: Ethanol 04hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	Ethanol 04hrs	NA
SRR1736594	SRX825303	SRS804750	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq INPUT ethanol 4 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: Ethanol 04hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	Ethanol 04hrs	NA
SRR1736601	SRX825306	SRS804770	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq INPUT ethanol 12 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: Ethanol 12hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	Ethanol 12hrs	NA
SRR1736617	SRX825215	SRS804771	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq STAT3 ethanol 36 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: Ethanol 36hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	Ethanol 36hrs	NA
SRR1736612	SRX825307	SRS804771	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq INPUT ethanol 36 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: Ethanol 36hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	Ethanol 36hrs	NA
SRR1736613	SRX825307	SRS804771	SRP051593	NA	NA	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	ChIP-seq INPUT ethanol 36 hr MCF10A-ER-Src	NA	isolate: MCF10A-Er-Src || age: not collected || biomaterial_provider: Kevin Struhl || sex: female || tissue: breast || cell_line: MCF10A || cell_subtype: MCF10A-Er-Src || cell_type: Epithelial || treatment: Ethanol 36hrs || BioSampleModel: Human	NA	breast -;- MCF10A-Er-Src -;- Epithelial	NA	NA	NA	NA	NA	Ethanol 36hrs	NA
SRR1786526	SRX865038	SRS836544	SRP053186	GSM1601740	GSE65621	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	input_S3KO_IL27_1710; Mus musculus; ChIP-Seq	GSM1601740	source_name: mouse primary CD4+ T cells || strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL27) || genotype: STAT3 KO || chip antibody: none, input || lab data id: 1710	strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL27) || genotype: STAT3 KO || chip antibody: none, input || lab data id: 1710	C57BL/6 -;- mouse primary CD4+ T cells	NA	none, input	none, input	STAT3 KO	STAT3 KO	NA	NA
SRR1786525	SRX865037	SRS836545	SRP053186	GSM1601739	GSE65621	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	STAT1_S3KO_IL27_1708; Mus musculus; ChIP-Seq	GSM1601739	source_name: mouse primary CD4+ T cells || strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL27) || genotype: STAT3 KO || chip antibody: STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209) || lab data id: 1708	strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL27) || genotype: STAT3 KO || chip antibody: STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209) || lab data id: 1708	C57BL/6 -;- mouse primary CD4+ T cells	NA	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	STAT3 KO	STAT3 KO	NA	NA
SRR1786524	SRX865036	SRS836546	SRP053186	GSM1601738	GSE65621	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	input_S3KO_IL6_1707; Mus musculus; ChIP-Seq	GSM1601738	source_name: mouse primary CD4+ T cells || strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL6) || genotype: STAT3 KO || chip antibody: none, input || lab data id: 1707	strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL6) || genotype: STAT3 KO || chip antibody: none, input || lab data id: 1707	C57BL/6 -;- mouse primary CD4+ T cells	NA	none, input	none, input	STAT3 KO	STAT3 KO	NA	NA
SRR1786522	SRX865034	SRS836547	SRP053186	GSM1601736	GSE65621	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	STAT1_S3KO_IL6_1704; Mus musculus; ChIP-Seq	GSM1601736	source_name: mouse primary CD4+ T cells || strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL6) || genotype: STAT3 KO || chip antibody: STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209) || lab data id: 1704	strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL6) || genotype: STAT3 KO || chip antibody: STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209) || lab data id: 1704	C57BL/6 -;- mouse primary CD4+ T cells	NA	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	STAT3 KO	STAT3 KO	NA	NA
SRR1786523	SRX865035	SRS836548	SRP053186	GSM1601737	GSE65621	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	input_S3KO_nc_1706; Mus musculus; ChIP-Seq	GSM1601737	source_name: mouse primary CD4+ T cells || strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0 || genotype: STAT3 KO || chip antibody: none, input || lab data id: 1706	strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0 || genotype: STAT3 KO || chip antibody: none, input || lab data id: 1706	C57BL/6 -;- mouse primary CD4+ T cells	NA	none, input	none, input	STAT3 KO	STAT3 KO	NA	NA
SRR1786520	SRX865032	SRS836549	SRP053186	GSM1601734	GSE65621	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	STAT1_S3KO_nc_1701; Mus musculus; ChIP-Seq	GSM1601734	source_name: mouse primary CD4+ T cells || strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0 || genotype: STAT3 KO || chip antibody: STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209) || lab data id: 1701	strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0 || genotype: STAT3 KO || chip antibody: STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209) || lab data id: 1701	C57BL/6 -;- mouse primary CD4+ T cells	NA	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	STAT1 (Santa Cruz Biotechnology, sc-592)(Lot #E1209)	STAT3 KO	STAT3 KO	NA	NA
SRR1786521	SRX865033	SRS836550	SRP053186	GSM1601735	GSE65621	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	input_S1KO_IL27_1703; Mus musculus; ChIP-Seq	GSM1601735	source_name: mouse primary CD4+ T cells || strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL27) || genotype: STAT1 KO || chip antibody: none, input || lab data id: 1703	strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL27) || genotype: STAT1 KO || chip antibody: none, input || lab data id: 1703	C57BL/6 -;- mouse primary CD4+ T cells	NA	none, input	none, input	STAT1 KO	STAT1 KO	NA	NA
SRR1786516	SRX865028	SRS836551	SRP053186	GSM1601730	GSE65621	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	input_S1KO_nc_1695; Mus musculus; ChIP-Seq	GSM1601730	source_name: mouse primary CD4+ T cells || strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0 || genotype: STAT1 KO || chip antibody: none, input_ || lab data id: 1695	strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0 || genotype: STAT1 KO || chip antibody: none, input_ || lab data id: 1695	C57BL/6 -;- mouse primary CD4+ T cells	NA	none, input_	none, input_	STAT1 KO	STAT1 KO	NA	NA
SRR1786515	SRX865027	SRS836552	SRP053186	GSM1601729	GSE65621	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	input_WT_IL27_1694; Mus musculus; ChIP-Seq	GSM1601729	source_name: mouse primary CD4+ T cells || strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL27) || genotype: wild type || chip antibody: none, input_ || lab data id: 1694	strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL27) || genotype: wild type || chip antibody: none, input_ || lab data id: 1694	C57BL/6 -;- mouse primary CD4+ T cells	NA	none, input_	none, input_	wild type	wild type	NA	NA
SRR1786518	SRX865030	SRS836554	SRP053186	GSM1601732	GSE65621	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	input_S1KO_IL6_1699; Mus musculus; ChIP-Seq	GSM1601732	source_name: mouse primary CD4+ T cells || strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL6) || genotype: STAT1 KO || chip antibody: none, input || lab data id: 1699	strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL6) || genotype: STAT1 KO || chip antibody: none, input || lab data id: 1699	C57BL/6 -;- mouse primary CD4+ T cells	NA	none, input	none, input	STAT1 KO	STAT1 KO	NA	NA
SRR1786513	SRX865025	SRS836557	SRP053186	GSM1601727	GSE65621	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	input_WT_IL6_1691; Mus musculus; ChIP-Seq	GSM1601727	source_name: mouse primary CD4+ T cells || strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL6) || genotype: wild type || chip antibody: none, input_ || lab data id: 1691	strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0, treatment (IL6) || genotype: wild type || chip antibody: none, input_ || lab data id: 1691	C57BL/6 -;- mouse primary CD4+ T cells	NA	none, input_	none, input_	wild type	wild type	NA	NA
SRR1786509	SRX865021	SRS836564	SRP053186	GSM1601723	GSE65621	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	input_WT_nc_1687; Mus musculus; ChIP-Seq	GSM1601723	source_name: mouse primary CD4+ T cells || strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0 || genotype: wild type || chip antibody: none, input || lab data id: 1687	strain: C57BL/6 || culture condition: 3 day in vitro culture for Th0 || genotype: wild type || chip antibody: none, input || lab data id: 1687	C57BL/6 -;- mouse primary CD4+ T cells	NA	none, input	none, input	wild type	wild type	NA	NA
SRR1925780	SRX965495	SRS881085	SRP056442	GSM1641318	GSE67183	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	input DNA; Homo sapiens; ChIP-Seq	GSM1641318	source_name: Th17 cells || antibody: none	antibody: none	Th17 cells	NA	none	none	NA	NA	NA	NA
SRR1925779	SRX965494	SRS881086	SRP056442	GSM1641317	GSE67183	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	STAT3 ChIP-seq; Homo sapiens; ChIP-Seq	GSM1641317	source_name: Th17 cells || antibody: anti-STAT3	antibody: anti-STAT3 || catalog#/vendor: rabbit polyclonal αSTAT3 3291L, Cell Signaling Technology	Th17 cells	NA	anti-STAT3	anti-STAT3	NA	NA	NA	NA
SRR2758917	SRX1365213	SRS1127310	SRP065177	GSM1915813	GSE74262	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	mmDC_SAHA-STAT3_ChIPSeq; Mus musculus; ChIP-Seq	GSM1915813	source_name: Dendritic cells || strain: C57BL/6 || cell type: Bone marrow derived dendritic cells || agent: SAHA (500nm) || Sex: female || age: 10 weeks || chip antibody: STAT3 (Cat. 9132, Cell Signaling)	strain: C57BL/6 || cell type: Bone marrow derived dendritic cells || agent: SAHA (500nm) || Sex: female || age: 10 weeks || chip antibody: STAT3 (Cat. 9132, Cell Signaling)	C57BL/6 -;- Dendritic cells -;- Bone marrow derived dendritic cells	Bone marrow derived dendritic cells	STAT3 (Cat. 9132, Cell Signaling)	STAT3 (Cat. 9132, Cell Signaling)	NA	NA	NA	NA
SRR2758916	SRX1365212	SRS1127312	SRP065177	GSM1915812	GSE74262	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	mmDC_STAT3_ChIPSeq; Mus musculus; ChIP-Seq	GSM1915812	source_name: Dendritic cells || strain: C57BL/6 || cell type: Bone marrow derived dendritic cells || agent: diluent || Sex: female || age: 10 weeks || chip antibody: STAT3 (Cat. 9132, Cell Signaling)	strain: C57BL/6 || cell type: Bone marrow derived dendritic cells || agent: diluent || Sex: female || age: 10 weeks || chip antibody: STAT3 (Cat. 9132, Cell Signaling)	C57BL/6 -;- Dendritic cells -;- Bone marrow derived dendritic cells	Bone marrow derived dendritic cells	STAT3 (Cat. 9132, Cell Signaling)	STAT3 (Cat. 9132, Cell Signaling)	NA	NA	NA	NA
SRR2758915	SRX1365211	SRS1127313	SRP065177	GSM1915811	GSE74262	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	mmDC_IgG_ChIPSeq; Mus musculus; ChIP-Seq	GSM1915811	source_name: Dendritic cells || strain: C57BL/6 || cell type: Bone marrow derived dendritic cells || agent: diluent || Sex: female || age: 10 weeks || chip antibody: Rabbit IgG (Cat. 2729, Cell Signaling)	strain: C57BL/6 || cell type: Bone marrow derived dendritic cells || agent: diluent || Sex: female || age: 10 weeks || chip antibody: Rabbit IgG (Cat. 2729, Cell Signaling)	C57BL/6 -;- Dendritic cells -;- Bone marrow derived dendritic cells	Bone marrow derived dendritic cells	Rabbit IgG (Cat. 2729, Cell Signaling)	Rabbit IgG (Cat. 2729, Cell Signaling)	NA	NA	NA	NA
SRR3631996	SRX1823764	SRS1486795	SRP076178	GSM2188457	GSE82295,GSE82297	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	DIF_INPUT_A; Homo sapiens; ChIP-Seq	GSM2188457	source_name: DIF_INPUT || immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: differentiated for 5 days into osteoblastic lineage || treatment: DMSO || chip antibody: none	immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: differentiated for 5 days into osteoblastic lineage || treatment: DMSO || chip antibody: none	DIF_INPUT -;- human Fetal Osteoblasts (hFOB)	human Fetal Osteoblasts (hFOB)	none	none	NA	NA	DMSO	DMSO
SRR3631997	SRX1823765	SRS1486796	SRP076178	GSM2188458	GSE82295,GSE82297	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	DIF_INPUT_B; Homo sapiens; ChIP-Seq	GSM2188458	source_name: DIF_INPUT || immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: differentiated for 5 days into osteoblastic lineage || treatment: DMSO || chip antibody: none	immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: differentiated for 5 days into osteoblastic lineage || treatment: DMSO || chip antibody: none	DIF_INPUT -;- human Fetal Osteoblasts (hFOB)	human Fetal Osteoblasts (hFOB)	none	none	NA	NA	DMSO	DMSO
SRR3631998	SRX1823766	SRS1486797	SRP076178	GSM2188459	GSE82295,GSE82297	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	DIF_INPUT_C; Homo sapiens; ChIP-Seq	GSM2188459	source_name: DIF_INPUT || immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: differentiated for 5 days into osteoblastic lineage || treatment: DMSO || chip antibody: none	immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: differentiated for 5 days into osteoblastic lineage || treatment: DMSO || chip antibody: none	DIF_INPUT -;- human Fetal Osteoblasts (hFOB)	human Fetal Osteoblasts (hFOB)	none	none	NA	NA	DMSO	DMSO
SRR3631999	SRX1823767	SRS1486798	SRP076178	GSM2188460	GSE82295,GSE82297	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	DIF_JQ1_INPUT_A; Homo sapiens; ChIP-Seq	GSM2188460	source_name: DIF_JQ1_INPUT || immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: differentiated for 5 days into osteoblastic lineage || treatment: JQ1 || chip antibody: none	immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: differentiated for 5 days into osteoblastic lineage || treatment: JQ1 || chip antibody: none	DIF_JQ1_INPUT -;- human Fetal Osteoblasts (hFOB)	human Fetal Osteoblasts (hFOB)	none	none	NA	NA	JQ1	JQ1
SRR3632000	SRX1823768	SRS1486799	SRP076178	GSM2188461	GSE82295,GSE82297	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	DIF_JQ1_INPUT_B; Homo sapiens; ChIP-Seq	GSM2188461	source_name: DIF_JQ1_INPUT || immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: differentiated for 5 days into osteoblastic lineage || treatment: JQ1 || chip antibody: none	immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: differentiated for 5 days into osteoblastic lineage || treatment: JQ1 || chip antibody: none	DIF_JQ1_INPUT -;- human Fetal Osteoblasts (hFOB)	human Fetal Osteoblasts (hFOB)	none	none	NA	NA	JQ1	JQ1
SRR3632001	SRX1823769	SRS1486800	SRP076178	GSM2188462	GSE82295,GSE82297	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	UND_INPUT_A; Homo sapiens; ChIP-Seq	GSM2188462	source_name: UND_INPUT || immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: undifferentiated || treatment: DMSO || chip antibody: none	immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: undifferentiated || treatment: DMSO || chip antibody: none	UND_INPUT -;- human Fetal Osteoblasts (hFOB)	human Fetal Osteoblasts (hFOB)	none	none	NA	NA	DMSO	DMSO
SRR3632002	SRX1823770	SRS1486801	SRP076178	GSM2188463	GSE82295,GSE82297	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	UND_INPUT_B; Homo sapiens; ChIP-Seq	GSM2188463	source_name: UND_INPUT || immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: undifferentiated || treatment: DMSO || chip antibody: none	immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: undifferentiated || treatment: DMSO || chip antibody: none	UND_INPUT -;- human Fetal Osteoblasts (hFOB)	human Fetal Osteoblasts (hFOB)	none	none	NA	NA	DMSO	DMSO
SRR3632003	SRX1823771	SRS1486802	SRP076178	GSM2188464	GSE82295,GSE82297	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	UND_INPUT_C; Homo sapiens; ChIP-Seq	GSM2188464	source_name: UND_INPUT || immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: undifferentiated || treatment: DMSO || chip antibody: none	immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: undifferentiated || treatment: DMSO || chip antibody: none	UND_INPUT -;- human Fetal Osteoblasts (hFOB)	human Fetal Osteoblasts (hFOB)	none	none	NA	NA	DMSO	DMSO
SRR3632049	SRX1823817	SRS1486848	SRP076178	GSM2188510	GSE82295,GSE82297	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	DIF_STAT3_A; Homo sapiens; ChIP-Seq	GSM2188510	source_name: DIF_STAT3 || immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: differentiated for 5 days into osteoblastic lineage || chip antibody: Santa Cruz, sc-482, C-20	immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: differentiated for 5 days into osteoblastic lineage || chip antibody: Santa Cruz, sc-482, C-20	DIF_STAT3 -;- human Fetal Osteoblasts (hFOB)	human Fetal Osteoblasts (hFOB)	Santa Cruz, sc-482, C-20	Santa Cruz, sc-482, C-20	NA	NA	NA	NA
SRR3632050	SRX1823818	SRS1486849	SRP076178	GSM2188511	GSE82295,GSE82297	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	DIF_STAT3_B; Homo sapiens; ChIP-Seq	GSM2188511	source_name: DIF_STAT3 || immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: differentiated for 5 days into osteoblastic lineage || chip antibody: Santa Cruz, sc-482, C-20	immortalization type: SV40 large T antigen immortalized || cell type: human Fetal Osteoblasts (hFOB) || protocol: differentiated for 5 days into osteoblastic lineage || chip antibody: Santa Cruz, sc-482, C-20	DIF_STAT3 -;- human Fetal Osteoblasts (hFOB)	human Fetal Osteoblasts (hFOB)	Santa Cruz, sc-482, C-20	Santa Cruz, sc-482, C-20	NA	NA	NA	NA
SRR3632053	SRX1823821	SRS1486852	SRP076178	GSM2188514	GSE82295,GSE82297	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	L3.6_INPUT_A; Homo sapiens; ChIP-Seq	GSM2188514	source_name: L3.6_INPUT || cell type: L3.6 pancreatic cancer cells || chip antibody: none	cell type: L3.6 pancreatic cancer cells || chip antibody: none	L3.6_INPUT -;- L3.6 pancreatic cancer cells	L3.6 pancreatic cancer cells	none	none	NA	NA	NA	NA
SRR3632054	SRX1823822	SRS1486853	SRP076178	GSM2188515	GSE82295,GSE82297	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	L3.6_INPUT_B; Homo sapiens; ChIP-Seq	GSM2188515	source_name: L3.6_INPUT || cell type: L3.6 pancreatic cancer cells || chip antibody: none	cell type: L3.6 pancreatic cancer cells || chip antibody: none	L3.6_INPUT -;- L3.6 pancreatic cancer cells	L3.6 pancreatic cancer cells	none	none	NA	NA	NA	NA
SRR4029217	SRX2020839	SRS1615529	SRP081918	GSM2278001	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	MDAMB157_STAT3_Rep2; Homo sapiens; ChIP-Seq	GSM2278001	source_name: MDA-MB-157 cells || cell line: MDA-MB-157 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: MDA-MB-157 (Human Medulallary Carcinoma)	cell line: MDA-MB-157 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: MDA-MB-157 (Human Medulallary Carcinoma)	MDA-MB-157 cells -;- MDA-MB-157 (Human Medulallary Carcinoma)	MDA-MB-157 (Human Medulallary Carcinoma)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	NA	NA	ethanol	ethanol
SRR4029216	SRX2020838	SRS1615530	SRP081918	GSM2278000	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	MDAMB157_STAT3_Rep1; Homo sapiens; ChIP-Seq	GSM2278000	source_name: MDA-MB-157 cells || cell line: MDA-MB-157 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: MDA-MB-157 (Human Medulallary Carcinoma)	cell line: MDA-MB-157 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: MDA-MB-157 (Human Medulallary Carcinoma)	MDA-MB-157 cells -;- MDA-MB-157 (Human Medulallary Carcinoma)	MDA-MB-157 (Human Medulallary Carcinoma)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	NA	NA	ethanol	ethanol
SRR4029218	SRX2020840	SRS1615531	SRP081918	GSM2278002	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	MDAMB231_STAT3_Rep1; Homo sapiens; ChIP-Seq	GSM2278002	source_name: MDA-MB-231 cells || cell line: MDA-MB-231 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: MDA-MB-231 (Human Adenocarcinoma)	cell line: MDA-MB-231 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: MDA-MB-231 (Human Adenocarcinoma)	MDA-MB-231 cells -;- MDA-MB-231 (Human Adenocarcinoma)	MDA-MB-231 (Human Adenocarcinoma)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	NA	NA	ethanol	ethanol
SRR4029219	SRX2020841	SRS1615532	SRP081918	GSM2278003	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	MDAMB231_STAT3_Rep2; Homo sapiens; ChIP-Seq	GSM2278003	source_name: MDA-MB-231 cells || cell line: MDA-MB-231 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: MDA-MB-231 (Human Adenocarcinoma)	cell line: MDA-MB-231 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: MDA-MB-231 (Human Adenocarcinoma)	MDA-MB-231 cells -;- MDA-MB-231 (Human Adenocarcinoma)	MDA-MB-231 (Human Adenocarcinoma)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	NA	NA	ethanol	ethanol
SRR4029220	SRX2020842	SRS1615533	SRP081918	GSM2278004	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	HCC70_STAT3_Rep1; Homo sapiens; ChIP-Seq	GSM2278004	source_name: HCC70 cells || cell line: HCC70 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	cell line: HCC70 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	HCC70 cells -;- HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	NA	NA	ethanol	ethanol
SRR4029221	SRX2020843	SRS1615534	SRP081918	GSM2278005	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	HCC70_STAT3_Rep2; Homo sapiens; ChIP-Seq	GSM2278005	source_name: HCC70 cells || cell line: HCC70 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	cell line: HCC70 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	HCC70 cells -;- HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	NA	NA	ethanol	ethanol
SRR4029222	SRX2020844	SRS1615535	SRP081918	GSM2278006	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	A139_STAT3_Rep1; Homo sapiens; ChIP-Seq	GSM2278006	source_name: A139 tumor cells || tumor: Tumor A139 || treatment: N/A || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482)	tumor: Tumor A139 || treatment: N/A || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482)	A139 tumor cells	NA	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	NA	NA	N/A	N/A
SRR4029223	SRX2020845	SRS1615536	SRP081918	GSM2278007	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	A137_STAT3_Rep1; Homo sapiens; ChIP-Seq	GSM2278007	source_name: A137 tumor cells || tumor: Tumor A137 || treatment: N/A || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482)	tumor: Tumor A137 || treatment: N/A || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482)	A137 tumor cells	NA	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	NA	NA	N/A	N/A
SRR4029224	SRX2020846	SRS1615537	SRP081918	GSM2278008	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	MDAMB468_STAT3_Rep1; Homo sapiens; ChIP-Seq	GSM2278008	source_name: MDA-MB-468 cells || cell line: MDA-MB-468 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: MDA-MB-468 (Human adenocarcinoma)	cell line: MDA-MB-468 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: MDA-MB-468 (Human adenocarcinoma)	MDA-MB-468 cells -;- MDA-MB-468 (Human adenocarcinoma)	MDA-MB-468 (Human adenocarcinoma)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	NA	NA	ethanol	ethanol
SRR4029226	SRX2020848	SRS1615538	SRP081918	GSM2278010	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	HCC1143_STAT3_Rep1; Homo sapiens; ChIP-Seq	GSM2278010	source_name: HCC1143 cells || cell line: HCC1143 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	cell line: HCC1143 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	HCC1143 cells -;- HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	NA	NA	ethanol	ethanol
SRR4029227	SRX2020849	SRS1615539	SRP081918	GSM2278011	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	HCC1143_STAT3_Rep2; Homo sapiens; ChIP-Seq	GSM2278011	source_name: HCC1143 cells || cell line: HCC1143 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	cell line: HCC1143 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	HCC1143 cells -;- HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	NA	NA	ethanol	ethanol
SRR4029225	SRX2020847	SRS1615540	SRP081918	GSM2278009	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	MDAMB468_STAT3_Rep2; Homo sapiens; ChIP-Seq	GSM2278009	source_name: MDA-MB-468 cells || cell line: MDA-MB-468 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: MDA-MB-468 (Human adenocarcinoma)	cell line: MDA-MB-468 || treatment: ethanol || chip-seq antibody: anti-STAT3 (Santa Cruz Biotechnology, sc-482) || cell type: MDA-MB-468 (Human adenocarcinoma)	MDA-MB-468 cells -;- MDA-MB-468 (Human adenocarcinoma)	MDA-MB-468 (Human adenocarcinoma)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	anti-STAT3 (Santa Cruz Biotechnology, sc-482)	NA	NA	ethanol	ethanol
SRR4029229	SRX2020851	SRS1615541	SRP081918	GSM2278013	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	MDAMB157_STAT3_Rep2_Input_Control; Homo sapiens; ChIP-Seq	GSM2278013	source_name: MDA-MB-157 cells || cell line: MDA-MB-157 || treatment: ethanol || chip-seq antibody: none (input) || cell type: MDA-MB-157 (Human Medulallary Carcinoma)	cell line: MDA-MB-157 || treatment: ethanol || chip-seq antibody: none (input) || cell type: MDA-MB-157 (Human Medulallary Carcinoma)	MDA-MB-157 cells -;- MDA-MB-157 (Human Medulallary Carcinoma)	MDA-MB-157 (Human Medulallary Carcinoma)	none (input)	none (input)	NA	NA	ethanol	ethanol
SRR4029230	SRX2020852	SRS1615542	SRP081918	GSM2278014	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	MDAMB231_STAT3_Rep1_Input_Control; Homo sapiens; ChIP-Seq	GSM2278014	source_name: MDA-MB-231 cells || cell line: MDA-MB-231 || treatment: ethanol || chip-seq antibody: none (input) || cell type: MDA-MB-231 (Human Adenocarcinoma)	cell line: MDA-MB-231 || treatment: ethanol || chip-seq antibody: none (input) || cell type: MDA-MB-231 (Human Adenocarcinoma)	MDA-MB-231 cells -;- MDA-MB-231 (Human Adenocarcinoma)	MDA-MB-231 (Human Adenocarcinoma)	none (input)	none (input)	NA	NA	ethanol	ethanol
SRR4029228	SRX2020850	SRS1615543	SRP081918	GSM2278012	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	MDAMB157_STAT3_Rep1_Input_Control; Homo sapiens; ChIP-Seq	GSM2278012	source_name: MDA-MB-157 cells || cell line: MDA-MB-157 || treatment: ethanol || chip-seq antibody: none (input) || cell type: MDA-MB-157 (Human Medulallary Carcinoma)	cell line: MDA-MB-157 || treatment: ethanol || chip-seq antibody: none (input) || cell type: MDA-MB-157 (Human Medulallary Carcinoma)	MDA-MB-157 cells -;- MDA-MB-157 (Human Medulallary Carcinoma)	MDA-MB-157 (Human Medulallary Carcinoma)	none (input)	none (input)	NA	NA	ethanol	ethanol
SRR4029231	SRX2020853	SRS1615544	SRP081918	GSM2278015	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	MDAMB231_STAT3_Rep2_Input_Control; Homo sapiens; ChIP-Seq	GSM2278015	source_name: MDA-MB-231 cells || cell line: MDA-MB-231 || treatment: ethanol || chip-seq antibody: none (input) || cell type: MDA-MB-231 (Human Adenocarcinoma)	cell line: MDA-MB-231 || treatment: ethanol || chip-seq antibody: none (input) || cell type: MDA-MB-231 (Human Adenocarcinoma)	MDA-MB-231 cells -;- MDA-MB-231 (Human Adenocarcinoma)	MDA-MB-231 (Human Adenocarcinoma)	none (input)	none (input)	NA	NA	ethanol	ethanol
SRR4029233	SRX2020855	SRS1615545	SRP081918	GSM2278017	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	HCC70_STAT3_Rep2_Input_Control; Homo sapiens; ChIP-Seq	GSM2278017	source_name: HCC70 cells || cell line: HCC70 || treatment: ethanol || chip-seq antibody: none (input) || cell type: HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	cell line: HCC70 || treatment: ethanol || chip-seq antibody: none (input) || cell type: HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	HCC70 cells -;- HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	none (input)	none (input)	NA	NA	ethanol	ethanol
SRR4029232	SRX2020854	SRS1615546	SRP081918	GSM2278016	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	HCC70_STAT3_Rep1_Input_Control; Homo sapiens; ChIP-Seq	GSM2278016	source_name: HCC70 cells || cell line: HCC70 || treatment: ethanol || chip-seq antibody: none (input) || cell type: HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	cell line: HCC70 || treatment: ethanol || chip-seq antibody: none (input) || cell type: HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	HCC70 cells -;- HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	HCC70 (Human Tnm Stage Iiia, Grade 3, Primary Ductal Carcinoma)	none (input)	none (input)	NA	NA	ethanol	ethanol
SRR4029234	SRX2020856	SRS1615547	SRP081918	GSM2278018	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	A139_STAT3_Input_Control; Homo sapiens; ChIP-Seq	GSM2278018	source_name: A139 tumor cells || tumor: Tumor A139 || treatment: N/A || chip-seq antibody: none (input)	tumor: Tumor A139 || treatment: N/A || chip-seq antibody: none (input)	A139 tumor cells	NA	none (input)	none (input)	NA	NA	N/A	N/A
SRR4029235	SRX2020857	SRS1615548	SRP081918	GSM2278019	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	A137_STAT3_Input_Control; Homo sapiens; ChIP-Seq	GSM2278019	source_name: A137 tumor cells || tumor: Tumor A137 || treatment: N/A || chip-seq antibody: none (input)	tumor: Tumor A137 || treatment: N/A || chip-seq antibody: none (input)	A137 tumor cells	NA	none (input)	none (input)	NA	NA	N/A	N/A
SRR4029236	SRX2020858	SRS1615549	SRP081918	GSM2278020	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	MDAMB468_STAT3_Rep1_Input_Control; Homo sapiens; ChIP-Seq	GSM2278020	source_name: MDA-MB-468 cells || cell line: MDA-MB-468 || treatment: ethanol || chip-seq antibody: none (input) || cell type: MDA-MB-468 (Human adenocarcinoma)	cell line: MDA-MB-468 || treatment: ethanol || chip-seq antibody: none (input) || cell type: MDA-MB-468 (Human adenocarcinoma)	MDA-MB-468 cells -;- MDA-MB-468 (Human adenocarcinoma)	MDA-MB-468 (Human adenocarcinoma)	none (input)	none (input)	NA	NA	ethanol	ethanol
SRR4029237	SRX2020859	SRS1615550	SRP081918	GSM2278021	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	MDAMB468_STAT3_Rep2_Input_Control; Homo sapiens; ChIP-Seq	GSM2278021	source_name: MDA-MB-468 cells || cell line: MDA-MB-468 || treatment: ethanol || chip-seq antibody: none (input) || cell type: MDA-MB-468 (Human adenocarcinoma)	cell line: MDA-MB-468 || treatment: ethanol || chip-seq antibody: none (input) || cell type: MDA-MB-468 (Human adenocarcinoma)	MDA-MB-468 cells -;- MDA-MB-468 (Human adenocarcinoma)	MDA-MB-468 (Human adenocarcinoma)	none (input)	none (input)	NA	NA	ethanol	ethanol
SRR4029238	SRX2020860	SRS1615551	SRP081918	GSM2278022	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	HCC1143_STAT3_Rep1_Input_Control; Homo sapiens; ChIP-Seq	GSM2278022	source_name: HCC1143 cells || cell line: HCC1143 || treatment: ethanol || chip-seq antibody: none (input) || cell type: HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	cell line: HCC1143 || treatment: ethanol || chip-seq antibody: none (input) || cell type: HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	HCC1143 cells -;- HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	none (input)	none (input)	NA	NA	ethanol	ethanol
SRR4029239	SRX2020861	SRS1615552	SRP081918	GSM2278023	GSE85579	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	HCC1143_STAT3_Rep2_Input_Control; Homo sapiens; ChIP-Seq	GSM2278023	source_name: HCC1143 cells || cell line: HCC1143 || treatment: ethanol || chip-seq antibody: none (input) || cell type: HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	cell line: HCC1143 || treatment: ethanol || chip-seq antibody: none (input) || cell type: HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	HCC1143 cells -;- HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	HCC1143 (Human TNM stage IIA, grade 3, primary ductal carcinoma)	none (input)	none (input)	NA	NA	ethanol	ethanol
SRR5366199	SRX2661478	SRS2063579	SRP102290	GSM2545818	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS78_1_Th17 input; Homo sapiens; ChIP-Seq	GSM2545818	source_name: Th17_input || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- Th17_input -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	NA	NA	NA	NA	NA	NA
SRR5366200	SRX2661478	SRS2063579	SRP102290	GSM2545818	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS78_1_Th17 input; Homo sapiens; ChIP-Seq	GSM2545818	source_name: Th17_input || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- Th17_input -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	NA	NA	NA	NA	NA	NA
SRR5366201	SRX2661479	SRS2063580	SRP102290	GSM2545819	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS78_2_Th17_STAT3; Homo sapiens; ChIP-Seq	GSM2545819	source_name: Th17_STAT3 || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	healthy neonates -;- Umbilical cord blood -;- Th17_STAT3 -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	NA	NA	NA	NA
SRR5366202	SRX2661479	SRS2063580	SRP102290	GSM2545819	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS78_2_Th17_STAT3; Homo sapiens; ChIP-Seq	GSM2545819	source_name: Th17_STAT3 || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	healthy neonates -;- Umbilical cord blood -;- Th17_STAT3 -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	NA	NA	NA	NA
SRR5366203	SRX2661479	SRS2063580	SRP102290	GSM2545819	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS78_2_Th17_STAT3; Homo sapiens; ChIP-Seq	GSM2545819	source_name: Th17_STAT3 || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	healthy neonates -;- Umbilical cord blood -;- Th17_STAT3 -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	NA	NA	NA	NA
SRR5366204	SRX2661480	SRS2063581	SRP102290	GSM2545820	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS80_Th17_PI input; Homo sapiens; ChIP-Seq	GSM2545820	source_name: Th17_input || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- Th17_input -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	NA	NA	NA	NA	NA	NA
SRR5366205	SRX2661480	SRS2063581	SRP102290	GSM2545820	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS80_Th17_PI input; Homo sapiens; ChIP-Seq	GSM2545820	source_name: Th17_input || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- Th17_input -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	NA	NA	NA	NA	NA	NA
SRR5366206	SRX2661480	SRS2063581	SRP102290	GSM2545820	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS80_Th17_PI input; Homo sapiens; ChIP-Seq	GSM2545820	source_name: Th17_input || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- Th17_input -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	NA	NA	NA	NA	NA	NA
SRR5366207	SRX2661481	SRS2063582	SRP102290	GSM2545821	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS80_Th17_PI STAT3; Homo sapiens; ChIP-Seq	GSM2545821	source_name: Th17_STAT3 || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	healthy neonates -;- Umbilical cord blood -;- Th17_STAT3 -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	NA	NA	NA	NA
SRR5366208	SRX2661481	SRS2063582	SRP102290	GSM2545821	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS80_Th17_PI STAT3; Homo sapiens; ChIP-Seq	GSM2545821	source_name: Th17_STAT3 || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	healthy neonates -;- Umbilical cord blood -;- Th17_STAT3 -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	NA	NA	NA	NA
SRR5366209	SRX2661481	SRS2063582	SRP102290	GSM2545821	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS80_Th17_PI STAT3; Homo sapiens; ChIP-Seq	GSM2545821	source_name: Th17_STAT3 || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	healthy neonates -;- Umbilical cord blood -;- Th17_STAT3 -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	NA	NA	NA	NA
SRR5366210	SRX2661482	SRS2063583	SRP102290	GSM2545822	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS80 Th17_PII input; Homo sapiens; ChIP-Seq	GSM2545822	source_name: Th17_input || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- Th17_input -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	NA	NA	NA	NA	NA	NA
SRR5366211	SRX2661482	SRS2063583	SRP102290	GSM2545822	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS80 Th17_PII input; Homo sapiens; ChIP-Seq	GSM2545822	source_name: Th17_input || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- Th17_input -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	NA	NA	NA	NA	NA	NA
SRR5366212	SRX2661483	SRS2063584	SRP102290	GSM2545823	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS80 Th17_PII STAT3; Homo sapiens; ChIP-Seq	GSM2545823	source_name: Th17_STAT3 || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	healthy neonates -;- Umbilical cord blood -;- Th17_STAT3 -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	NA	NA	NA	NA
SRR5366213	SRX2661483	SRS2063584	SRP102290	GSM2545823	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS80 Th17_PII STAT3; Homo sapiens; ChIP-Seq	GSM2545823	source_name: Th17_STAT3 || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	healthy neonates -;- Umbilical cord blood -;- Th17_STAT3 -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	NA	NA	NA	NA
SRR5366214	SRX2661483	SRS2063584	SRP102290	GSM2545823	GSE96912	ChIP-Seq	ILLUMINA	SINGLE - 	false	9606	NA	VS80 Th17_PII STAT3; Homo sapiens; ChIP-Seq	GSM2545823	source_name: Th17_STAT3 || tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	tissue: healthy neonates || tissue: Umbilical cord blood || cell type: primary human CD4+ T cells || chip antibody: polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	healthy neonates -;- Umbilical cord blood -;- Th17_STAT3 -;- primary human CD4+ T cells	healthy neonates -;- Umbilical cord blood -;- primary human CD4+ T cells	polyclonal anti-STAT3 antibody (rabbit polyclonal ÃŽÂ±STAT3 9132L, Cell Signaling Technology)	polyclonal anti-STAT3 antibody (rabbit polyclonal αSTAT3 9132L, Cell Signaling Technology)	NA	NA	NA	NA
SRR5647777	SRX2885380	SRS2253465	SRP108659	GSM2650745	GSE99708,GSE99797	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	Stat3 ChIP1; Mus musculus; ChIP-Seq	GSM2650745	source_name: OLP_Stat3 ChIP || strain: C57BL/6 || cell type: Primary Cortical Oligodendrocyte Progenitor (OLP) cells || treated with: 100ng/ml of CNTF (Peprotech) for 15 m || chip antibody: p-STAT3 (Y705) (Cell Signaling D3A7 Rb mAb 9145S Lot 26)	strain: C57BL/6 || cell type: Primary Cortical Oligodendrocyte Progenitor (OLP) cells || treated with: 100ng/ml of CNTF (Peprotech) for 15 m || chip antibody: p-STAT3 (Y705) (Cell Signaling D3A7 Rb mAb 9145S Lot 26)	C57BL/6 -;- OLP_Stat3 ChIP -;- Primary Cortical Oligodendrocyte Progenitor (OLP) cells	Primary Cortical Oligodendrocyte Progenitor (OLP) cells	p-STAT3 (Y705) (Cell Signaling D3A7 Rb mAb 9145S Lot 26)	p-STAT3 (Y705) (Cell Signaling D3A7 Rb mAb 9145S Lot 26)	NA	NA	100ng/ml of CNTF (Peprotech) for 15 m	NA
SRR5647778	SRX2885381	SRS2253466	SRP108659	GSM2650746	GSE99708,GSE99797	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	Stat3 ChIP2; Mus musculus; ChIP-Seq	GSM2650746	source_name: OLP_Stat3 ChIP || strain: C57BL/6 || cell type: Primary Cortical Oligodendrocyte Progenitor (OLP) cells || treated with: 100ng/ml of CNTF (Peprotech) for 15 m || chip antibody: p-STAT3 (Y705) (Cell Signaling D3A7 Rb mAb 9145S Lot 26)	strain: C57BL/6 || cell type: Primary Cortical Oligodendrocyte Progenitor (OLP) cells || treated with: 100ng/ml of CNTF (Peprotech) for 15 m || chip antibody: p-STAT3 (Y705) (Cell Signaling D3A7 Rb mAb 9145S Lot 26)	C57BL/6 -;- OLP_Stat3 ChIP -;- Primary Cortical Oligodendrocyte Progenitor (OLP) cells	Primary Cortical Oligodendrocyte Progenitor (OLP) cells	p-STAT3 (Y705) (Cell Signaling D3A7 Rb mAb 9145S Lot 26)	p-STAT3 (Y705) (Cell Signaling D3A7 Rb mAb 9145S Lot 26)	NA	NA	100ng/ml of CNTF (Peprotech) for 15 m	NA
SRR5647779	SRX2885382	SRS2253467	SRP108659	GSM2650747	GSE99708,GSE99797	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	Stat3 Input1; Mus musculus; ChIP-Seq	GSM2650747	source_name: OLP_Stat3 Input || strain: C57BL/6 || cell type: Primary Cortical Oligodendrocyte Progenitor (OLP) cells || treated with: 100ng/ml of CNTF (Peprotech) for 15 m || chip antibody: None	strain: C57BL/6 || cell type: Primary Cortical Oligodendrocyte Progenitor (OLP) cells || treated with: 100ng/ml of CNTF (Peprotech) for 15 m || chip antibody: None	C57BL/6 -;- OLP_Stat3 Input -;- Primary Cortical Oligodendrocyte Progenitor (OLP) cells	Primary Cortical Oligodendrocyte Progenitor (OLP) cells	None	None	NA	NA	100ng/ml of CNTF (Peprotech) for 15 m	NA
SRR5647780	SRX2885383	SRS2253468	SRP108659	GSM2650748	GSE99708,GSE99797	ChIP-Seq	ILLUMINA	SINGLE - 	false	10090	NA	Stat3 Input2; Mus musculus; ChIP-Seq	GSM2650748	source_name: OLP_Stat3 Input || strain: C57BL/6 || cell type: Primary Cortical Oligodendrocyte Progenitor (OLP) cells || treated with: 100ng/ml of CNTF (Peprotech) for 15 m || chip antibody: None	strain: C57BL/6 || cell type: Primary Cortical Oligodendrocyte Progenitor (OLP) cells || treated with: 100ng/ml of CNTF (Peprotech) for 15 m || chip antibody: None	C57BL/6 -;- OLP_Stat3 Input -;- Primary Cortical Oligodendrocyte Progenitor (OLP) cells	Primary Cortical Oligodendrocyte Progenitor (OLP) cells	None	None	NA	NA	100ng/ml of CNTF (Peprotech) for 15 m	NA
